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TREATMENT OUTCOMES OF THE SUMMER TREATMENT PROGRAM FOR
CHILDREN WITH ADHD AND COMORBID MENTAL HEALTH DIAGNOSES
ANTHONY REGIS PIZZUTI
ABSTRACT
Although there is substantial support for the efficacy of the Summer Treatment
Program (Pelham, Gnagy et al., 2010) for children diagnosed with attention deficit
hyperactivity disorder (ADHD), limited research has evaluated whether children
diagnosed with additional mental health disorders (comorbidity) show positive outcomes
and improvements when exposed to an intensive behavior program such as the Summer
Treatment Program (STP). Furthermore, there is no research available that shows
whether children from differing ages or gender who are diagnosed with additional mental
health disorders (comorbidity) show improvements over the course of treatment. With
such limited research, this study investigated a few of the questions raised about the
treatment outcomes of the STP and whether children diagnosed ADHD, with and without
comorbid conditions, have positive treatment outcomes and efficacy differences as a
function of comorbidity, gender and age.
This particular research study examined archival data from 345 children, aged 6
to 12 years old, who enrolled in a 7-week Summer Treatment Program from the summers
of 1999 – 2012. The dependent variable included the STP point system total weekly
points earned from the program utilized as the indicator of the rate of change. A series of
mixed-effects regression models were computed with the independent measures for age
group, gender comparisons, and ADHD comorbidity to address four research questions.
The results of this investigation indicated no significant difference for children diagnosed
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with ADHD alone in treatment outcomes from those children diagnosed with ADHD
comorbidity. Both children with ADHD alone and those with ADHD comorbidity made
treatment gains over the course of the program. Secondly, significant differences were
found between males and females diagnosed with ADHD comorbidity regarding
treatment outcomes, in that females earned significantly more points than males during
the summer treatment program. Thirdly, there were no significant age group differences
in treatment outcomes with children diagnosed with ADHD comorbidity. Lastly, of all
ADHD comorbid diagnoses, only Oppositional Defiant Disorder (ODD) was significantly
associated with lower weekly scores than children with a diagnosis of ADHD only.
The results indicate that treatment matching may reduce some of the clinical
uncertainty in the literature regarding treatment options for children diagnosed with
ADHD comorbidity.
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CHAPTER I
INTRODUCTION
ADHD is one of the most prevalent behavioral disorders of childhood in the
United States and internationally (Tzang, Chang, & Liu, 2009; Visser, Bitsko, Danielson,
Perou, & Blumberg, 2010). Roughly an estimated 9.5% of school-aged children are
affected by ADHD and an additional 3.7% have ADHD combined with a learning
disability (Center for Disease Control and Prevention [CDC], 2010; Pastor & Reuben,
2008). ADHD is a chronic illness that is characterized by abnormally high levels of
hyperactivity, impulsivity and inattention. These symptoms are known to severely impair
many domains of functioning including academic, behavioral, peer relationships, and
self-esteem. Often times, these cognitive, behavioral, and social problems in childhood
tend to be carried on through adolescence and well into adulthood (Barkley, 2003).
Evolving Concepts of ADHD
ADHD has been studied for well over the past 100 years; ADHD has taken on
upwards of 20 various diagnostic labels as descriptors for early childhood mental health
illnesses. Few reports were detailed before 1900, but one of the first researchers to
describe this disorder was Dr. George Still, a pediatrician who depicted young boys as
having a ‘defect of moral control’ (Still, 1902, p.1008). He detailed for the first time, a
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biological link for the unmanageable behavior that these young children had shown as
noted by their aggression and poor inhibition control (Barkley, 1990). Still suggested
that these, mostly 8 year old boys, were considered morally defective with a genetic bias
toward moral corruption, he believed this moral deficit represented the manifestation of
some morbid physical condition (Still, 1902, p.1165). He dismissed cases of poor child
rearing environments in his research. Twenty years later, ADHD was referred to as
“postencephalitic behavior disorder” by Dr. Franklin Ebaugh (1923), named after the
many children who survived the 1917-1918 encephalitis epidemic. Ebaugh linked severe
brain damage with severe behavioral problems and was first to describe the “hyperactive”
symptoms associated with ADHD today (Barkley, 2007).
Since Ebaugh’s first description of hyperactive symptoms, the term
“hyperactivity” changed over time to such terms as, "restlessness," "irritability," and
"overactivity." In the late 1930s, Dr. Charles Bradley (1937) accidently discovered the
effective use of amphetamines and is credited as the first physician to document the
success of Benzedrine to treat hyperactivity in children. While caring for children’s
headaches resulting from painful spinal taps, Bradley found that children’s headaches
were not particularly affected or relieved by the drug (Bradley, 1950, p. 25). Instead,
Benzedrine improved the behavior and school performance of over 30 children, as
indicated by a stronger interest in school, improved work habits, and reduction in
disruptive behaviors. The drug “calmed many of the children without dulling their
attention span” (Bradley, 1937, p. 578).
Calhoun, Greenwell-Iorillo, and Chug (1997) studied the historical
transformations of the labels and diagnostic categories of ADHD. They stated that the
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1940s and 1950s brought new terms describing children with behavior problems; the term
of choice was ‘distractibility’ by Strauss and Werner (1941) and Strauss and Lehtinen
(1947). By the 1950's the labels employed to describe the condition included ‘minimal
brain damage’ by Strauss and Kephart (1955) (Calhoun, Greenwell-Iorillo & Chug, 1997,
p. 244). Another diagnostic category used in the 1950s to describe the condition
included, "hyperkinetic impulse disorder," (Laufer, Denhoff, & Solomons, 1957, p. 38).
As a new and specific diagnostic category, they noted, hyperkinetic impulse disorder was
a behavior pattern that:
May be noted from early infancy on or not become prominent until five or six
years of age…Hyperactivity is the most striking item…There are also a short
attention span and poor powers of concentration, which are particularly noticeable
under school conditions…The child is impulsive…irritable and explosive, with a
low frustration tolerance. Poor school work is frequently quite prominent. (p. 38)
These terms and categories fell out of use during the end of the 1950s and 1960s as
researchers studied ADHD more closely. However, during this time, important
advancements in the use of psychiatric medicines occurred when Methylphenidate or
Ritalin was introduced in the United States and eventually approved by the Food and
Drug Administration in 1961 (Swanson, McBurnett, Christian, & Wigal, 1995). Even
today, stimulant medications, including Methylphenidate or Ritalin, continue to provide
benefits for individuals suffering from ADHD (Charach, Ickowicz, & Schachar, 2004).
In the early 1960s, Chess (1960) studied 82 children who were diagnosed as
hyperactive out of a total of 881 children seen in her practice. Instead of focusing on
theories of etiology in her 1960 publication, Chess focused on classification and clinical
descriptions of hyperactive children. She offered a straightforward definition of
hyperactivity: “The hyperactive child is one who carries out activities at a higher rate of
speed than the average child, or who is constantly in motion or both” (Chess, 1960, p.
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2379). According to Barkley (1990), Chess was able to differentiate hyperactivity from
traumatic brain injury; “Chess was significant for her attempt to divide the heterogeneous
group of hyperactive children into more homogeneous subgroups and for explicitly
separating the concept of hyperactivity from that of brain injury” (p. 10).
During the mid1960s, researchers were attempting to discover the definitive link
between various severities of brain damage and hyperactivity (Herbert, 1964; Rapin,
1964). Children and adolescents previously diagnosed with hyperkinetic impulse
disorder showed no evidence of brain damage (Chess, 1960). With researchers unable to
reach a consensus, Barkley (1990) stated that the term, ‘minimal brain damage,’ became
recognized as “vague, overinclusive, of little or no prescriptive value, and without much
neurological evidence” (p.10). ‘Minimal brain damage’ transitioned into a new label
called, ‘minimal brain dysfunction’ (MBD) which still pointed to central nervous system
deficiencies, but left little explanation of what the deficiency may be (Clements & Peters,
1962).
When the American Psychiatric Association (APA) offered assistance in
renaming various disorders during the late 1960s, the term ‘minimal brain dysfunction’
was deleted and with the introduction of the Diagnostic and Statistical Manual of Mental
Disorders-II (American Psychiatric Association, 1968), the new term "hyperkinetic
reaction of childhood” was added in the DSM-II. The work of Laufer et al. (1957) and
Chess (1960) is notable for two important developments. First, the new criteria allowed
for classifying hyperactive, impulsive behavior according to a central behavior symptom,
such as hyperactivity, as well as shifting from the use of diagnostic labels based on
etiology to taking into account the use of behavioral classification for ADHD. However,
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the diagnostic label would not last; “hyperkinetic reaction of childhood disorder”
provided little useful diagnostic information besides describing hyperactive behavior
(Barkley, 1990, p. 10).
From 1980 to 1994, the APA published the third, Diagnostic and Statistical
Manual of Mental Disorders-III (American Psychiatric Association, 1980) and the fourth,
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV, American
Psychiatric Association 1994) publications. The diagnosis changed from "attentiondeficit disorder" (ADD) and "Attention-deficit disorder with hyperactivity” (ADD-H) to,
“attention deficit hyperactivity disorder” (AD-HD). During this time, the APA defined
three sets of specifiers under the diagnosis of ADHD. Currently, children diagnosed with
ADHD fall into one of three specifiers, including predominately inattentive,
predominately hyperactive, or most commonly, combined type.
Etiology, Features and Prevalence of ADHD
The etiology of ADHD has dodged researchers for decades, but recent studies
suggest both a strong genetic link as well as biological factors, such as preterm delivery
and possibly maternal smoking during pregnancy (Biederman, 2005; Milberger,
Biederman, Faraone, Guite & Tsuang, 1997; Rowland, Lesesne, & Abramowitz, 2002).
ADHD is a neurobehavioral disorder that typically begins in childhood and is marked by
developmentally inappropriate problems with attention, organization, and hyperactivity
that impede the child’s functioning in the family, social, and academic realms (APA,
2000). DSM-IV delineates three subtypes of ADHD: (a) ADHD, combined type
(ADHD-C), encompassing persistent symptoms of inattention and hyperactivity; (b)
ADHD, predominately inattentive type (ADHD-I) referring to children (or adults) who
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meet the diagnostic criteria for inattention but not hyperactivity; and (c) ADHD,
predominately hyperactive-impulsive type (ADHD-HI) denoting individuals who meet
the criteria for hyperactivity and impulsivity but not inattention. Of the three subtypes,
the ADHD-HI is the least prevalent (Tzang et al., 2009).
More than twice as many boys as girls are diagnosed with ADHD (Pastor &
Reuben, 2008). Between 1997 and 2006, there was a 4% increase in the number of girls
diagnosed with ADHD in the U.S. versus a 2% increase in boys, which may signify
increasing sensitivity to ADHD in girls. Some studies reported that girls are more likely
to have the inattentions subtype, which is less overt, which could lead to misdiagnosis or
under-diagnosis in girls. However, other studies reported similar proportions of boys and
girls with the ADHD combined and predominately inattention subtypes (Tzang et al.,
2009). ADHD with comorbid LD was roughly twice as common in boys (Pastor &
Reuben, 2008).
Gender is the most predictable factor in the demographic distribution of ADHD in
the general population. The only reported ethnic variation in ADHD in the American
population is that the prevalence is lower in Latino families. According to the 2004-2006
National Health Interview Survey (NHIS), Latino children were less likely to be
diagnosed with ADHD than white or black children (Pastor & Reuben, 2008). However,
2007 data from the CDC’s National Center for Health Statistics revealed increases in
ADHD among Latino children though the prevalence was still lower for Latino children
than for other ethnic groups (Visser et al., 2010). The CDC researchers proposed that the
increase might reflect more acceptance of the ADHD diagnosis by Latino families, better
access to health care, or a combination of both.
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The role of socioeconomic status (SES) in ADHD prevalence is less consistent.
According to the NHIS, ADHD without LD was most common in children whose
mothers had completed high school but not college though older children with only
ADHD tended to have the most educated mothers (Pastor & Reuben, 2008). ADHD
combined with LD was most prevalent in children with the least educated mothers and
also in families headed by single mothers. Diagnosed ADHD is more common in
families with health insurance but the critical factor seems to be access to health care
rather than SES; ADHD diagnoses are equally common in children with private insurance
and Medicaid. Treatment with stimulant medication alone seems to be more prevalent
among low-income children in the U.S. and Canada, under very different health care
systems (Ter-Stepanian, Grizenko, Zappitelli, & Joober, 2010).
National surveys consistently report that the financial cost of ADHD carries a
heavy burden for families, schools, and the health care system (Pastor & Reuben, 2008).
A 2006 estimate placed the number of school-aged children (aged 5-17 years) with
diagnosed ADHD at 4.5 million. Schools report that the number of children with ADHD
in special education programs is rapidly increasing. According to parents’ reports, there
was a gradual but decisive increase in the number of children with ADHD between 2003
and 2007 (Visser et al., 2010). Apart from financial cost, untreated or inadequately
treated ADHD has serious human cost. ADHD interferes with academic achievement
and children with ADHD and comorbid conduct disorder (CD) are at high risk for
adolescent delinquent behavior and substance abuse (Molina et al., 2009). Young and
Amarasinghe (2010) emphasized that ADHD is a developmental disorder beginning in
early childhood and persisting into adulthood. Most research on ADHD has focused on
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school-age children. Young and Amarasinghe advocated for multimodal interventions
specially tailored to each developmental stage from preschool through adulthood.
Family Influences
ADHD is generally recognized as having genetic and environmental components,
though there is some disagreement on the magnitude of each respective influence. Some
may infer that because ADHD has biological roots, parents and families do not play a
role in the etiology, management, or treatment, therefore medication should be the
foremost treatment modality (Howe, 2010). From most perspectives, however, the
environment is extremely important in the expression of ADHD symptoms and
behaviors. Behavior modification centers on altering the child’s environment, which
cannot be accomplished without the efforts of parents, teachers, or other significant adults
in the natural environment.
Researchers studying ADHD, point to the diathesis-stress model (Brown &
Barlow, 1997; Monroe & Simons, 1991;Zuckerman, 1999) which suggested that some
persons can be more vulnerable than others to stressful environmental influences, which
then influences one’s psychopathology. Similarly, the diathesis-stress model of ADHD,
suggested that families, schools, and peer groups that display negative and punitive
attitudes toward inattention, impulsivity, and hyperactivity and offer minimal support for
the development of self-regulation skills are likely to perpetuate or intensify symptoms of
ADHD in vulnerable children (Carr, 1999). On the other hand, social systems that are
more accepting of inattention, impulsivity, and hyperactivity and offer opportunities for
building self-regulation skills are more likely to help biologically vulnerable children
develop self-discipline and control. Several key assumptions underlie the diathesis-stress

8

model. In the context of families, the model proposed that families struggling to deal
with multiple stressors with minimal social support and poor quality of life may use
parenting styles and patterns of family interaction that adversely affect children who are
vulnerable to ADHD. In addition, parents with this profile often have childhood histories
of ADHD symptoms. They may experience psychological distress as a result of caring
for a child with ADHD (Harpin 2005).
Lange et al. (2005) examined the family factors that are associated with attention
deficit hyperactivity disorder and emotional disorders in children and questions whether
parents of children with other behavioral or emotional disorders report problems similar
to parents of children with ADHD. To examine these issues, Lange et al. (2005)
compared parents of children with ADHD with parents of children with other emotional
disorders (such as depression or anxiety) and a control group of parents of children with
no emotional or behavioral disorders. The participants were 22 mothers and 13 fathers of
22 boys who scored above 63 for externalizing behaviors on the Child Behavior
Checklist (Achenbach, 1991) and had a DSM-IV diagnosis of ADHD, 20 mothers and 15
fathers of 20 boys with high scores for internalizing behaviors on the CBCL and
diagnosis of major depression, dysthymia, or an anxiety disorder, and 26 mothers and 16
fathers of 17 control group boys.
The parents were also assessed on family life events, perceived social support,
quality of life, family functioning, parenting styles, parenting satisfaction, general health,
and their perceptions of ADHD symptoms in their own childhood. As Lange et al.
(2005) expected, the two groups of parents whose children had ADHD or emotional
disorders reported higher levels of stress, lower social support, and decreased quality of
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life compared to the control group parents. Furthermore, the parents of children with
clinical diagnoses experienced more family stress. However, there were no notable
differences in the problems reported by the parents of children with ADHD and
emotional disorders. One distinction in parenting style was that the parents of children
with ADHD were more predisposed toward authoritarian parenting (Lange et al., 2005).
As anticipated, the parents of the two clinical groups of children reported lower parenting
satisfaction compared to the control group parents. Overall, the findings were essentially
consistent with prior research on the psychosocial factors associated with ADHD and
supported the diathesis-stress hypotheses. The most notable finding was the striking
similarity in the psychosocial profiles of families of children with ADHD and emotional
disorders.
Perhaps those similarities should not be surprising in view of the extent of ADHD
comorbidity. Efron and Sciberras (2010) reported that among 64 children ranging in age
from 4 to 9 years who were referred to a children’s hospital for evaluation in response to
suspected ADHD, one-third actually had a different primary diagnosis and three-quarters
of the children had one or more comorbid disorders. Although the figure for comorbity is
high, it is not extraordinary. As in most studies, the most common comorbid disorders
were ODD and LD. Given the high prevalence of comorbidity and the complex and
multifaceted nature of symptom profiles and psychosocial assessments, it would virtually
be impossible to treat ADHD with medication alone and without enlisting families as
active partners in treatment. Family stress only works to sustain or exacerbate ADHD.
In fact, parent behavior training programs for children with emotional and behavioral

10

disorders have strong empirical support (Pelham & Fabiano, 2001, 2008; Pelham &
Gnagy, 1999; Young & Amarasinghe (2010).
Drabick, Gadow, and Sprafkin (2006) examined the coexistence of conduct
disorder (CD) and depression in boys with ADHD who were evaluated in the diagnostic
stage of a research project on boys with emotional and behavioral disorders. The 248
boys, aged 6 to 10, were recruited from several sources including a child psychiatry
outpatient clinic, an ADHD parent support group, as well as referred by parents, schools,
or other professionals. A number of psychosocial factors emerged as predictors for the
development or escalation of conduct problems in children with ADHD. In particular,
harsh, detached, and inconsistent parenting practices were associated with CD. A family
milieu marked with low family cohesion, high conflict, and low marital satisfaction
predicted both CD and depression. Finally, social problems were linked with depression.
Drabick et al. noted that these relationships held regardless of whether the child’s
behavior was reported by a parent or teacher.
According to Drabick et al. (2006), their findings support the theory of shared risk
factors for ADHD and Conduct Disorder comorbity. In accordance with coercion theory,
parenting behaviors reflecting hostility, inconsistent discipline, and detachment from the
child predicted CD symptoms in the group of boys whose ADHD was reported by
mothers and CD and depressive symptoms in the teacher-described group. Low marital
satisfaction and low family cohesion were associated with depression, CD, and parenting
behaviors. The one finding that contrasted with the researchers’ expectations was that
academic and cognitive functioning were not associated with depression, although
Drabick et al. (2006) acknowledged that an earlier study by Biederman and colleagues
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also found no relationship between ADHD and school problems and depressive
symptoms.
Deault (2010) conducted a review of empirical literature from 2000-2008
examining parenting factors related to children’s ADHD, with particular emphasis on the
development of comorbid internalizing and externalizing problems and functional
impairments in the academic and social environment. A total of 22 studies (18
correlational studies and 4 longitudinal studies) met Deault’s inclusion criteria. The
overall findings indicated that ODD rather than ADHD was more closely linked with
negative parenting practices and family conflict. Factors potentially linked with
oppositional and conduct problems in children with ADHD included parental ADHD,
maternal depression, limited positive parent involvement, and family conflict. However,
the specific patterns among these factors, in relation to behavior problems, are uncertain.
More recently, comorbidity with ADHD has stepped to the front as one of the
most important aspects of this pervasive disorder (Brown, 2000; Jensen et al., 2001a,
2001b). Typically, rates of comorbidity with ADHD are high with boys presenting with
higher rates of ADHD than girls. According to, The Agency for Health Care Policy and
Research (AHCPR, 1999), a stronger presence of the externalizing disruptive behaviors
are reported with almost one third of children diagnosed with ADHD also being
diagnosed with oppositional defiant disorder (ODD) and one fourth of children diagnosed
with ADHD qualifying for a diagnosis of conduct disorder (CD). Overall, there are fewer
children diagnosed with internalizing disorders (depressive and anxiety) co-occurring
with ADHD than children diagnosed with externalizing problems (Oppositional Defiant
Disorder and Conduct Disorder) with ADHD. Less than one-fifth of children diagnosed
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with ADHD also present with a depressive disorder while more than one-fourth of
children diagnosed with ADHD have an additional anxiety disorder. Remarkably, almost
one-third of children diagnosed with ADHD also have more than one comorbid
condition. Overall, comorbid conditions range from 12.36% (learning disorders) to
35.15% (conduct disorder) in children. By definition, children diagnosed with ADHD
and a comorbid diagnosis will have substantial difficulties in many areas, owing to
increased psychopathology, necessitating treatment comprehensiveness for intervention
in all impaired domains (AHCPR, 1999).
Various psychosocial and other treatments have been undertaken and are widely
practiced interventions for ADHD, including traditional in-office psychotherapy, play
therapy, vitamins, restrictive diets, biofeedback, chiropractic care, perceptual motor
training, inner ear treatment, and pet therapy, among others. However, none of these
therapies have shown empirical support in successfully treating ADHD (Pelham &
Gnagy, 1999). Alternately, to improve daily living, treatments with sustained, intensive,
and comprehensive behavioral interventions are recommended and supported (Chronis,
Jones, & Raggi, 2006; Pelham & Gnagy, 1999). Although a number of treatment options
are available to parents of children diagnosed with attention-deficit/hyperactivity
disorder, Pelham and Gnagy (1999) stated only three approaches have been supported by
empirical data and research, including, “1) behavior modification, 2) central nervous
stimulants and 3) the combination of both” (p.225). Each of these three interventions has
shown effectiveness in the short term; however, no treatments have been promising to
positively impact adolescent or adult outcomes (Owens et al., 2003; Pelham & Gnagy,
1999).
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The only form of psychosocial treatment with demonstrated efficacy is behavioral
interventions for children suffering with ADHD. Behavioral treatments have been used
for children specifically diagnosed with ADHD for numerous years and have been used
to treat children variously described as aggressive, disruptive, or diagnosed with conduct
disorder (Pelham & Gnagy, 1999). Epidemiological studies and clinical studies of
comorbidity have suggested that the majority of children described as
disruptive/aggressive in early studies would have been diagnosed with ADHD (with or
without comorbid aggression, conduct disorder, or oppositional defiant disorder) had
DSM criteria been used (Gillberg, Gillberg, Rasmussen, Kadesjo, Soderstrom, &
Rastram, 2004). Thus, there is extensive literature on behavior treatments for ADHD,
covering hundreds of studies and thousands of children (Brestan & Eyberg (1998),
Eyberg, Nelson, & Boggs (2008); Pelham, Greiner & Gnagy., 1998; Wells et al., 2000a)
Researching behavioral treatments, or behavior modification, for children
diagnosed with ADHD is accompanied with challenges that are not shared readily by
research about medication management. For example, since behavioral treatment
involves changing the environment around the child (i.e., external management),
generalization of treatment effects to other environments (e.g., home, academic) is
dependent upon application of similar contingencies within these other settings. This is
different than medication management research, in which changes to the neurological
functioning of the child’s brain (e.g. internal management) is attained. Pharmacological
research, therefore, is less susceptible to problems of generalization of treatment effects
than behavioral research (e.g., with medication, if effective dose is identified, then effects
tend not to vary as a function of the child’s setting).
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Pelham and Gnagy (1999) found outpatient behavioral treatments or what they
called clinical behavior therapy, has a number of additional challenges. In many ways,
clinical behavioral therapy has limitations similar to those of central nervous system
stimulant medication. First, although children receiving clinical behavioral therapy
interventions improved greatly, “they are less likely than the active medication group to
normalize children on parent and teacher rating scales and large minorities of children
fail to show improvements with clinical behavioral therapy” (Pelham & Gnagy, 1999, p.
230). Although moving to a cost-reward system would in many cases dramatically
increase improvements, some parents and teachers are unable or unwilling to implement
complicated behavioral interventions. Even when parents and teachers are willing to
initiate comprehensive interventions, they typically do not continue them without
ongoing consultation. Furthermore, there is a lack of evidence of long term effects of
behavior therapy for children with ADHD similar to psychostimulant medication (Pelham
& Gnagy, 1999). Overall, demonstration of the continuation and/or maintenance of
treatment effects over time is one of the major concerns of those using behavioral
interventions with children. Research regarding how to maintain effects in the long run
has not been undertaken. Again, these limitations have led to a growing practice of using
a combination of treatments, medications, and behavioral treatments.
One study of particular interest (also discussed in chapter 2) that has examined the
effectiveness of using a combination of treatments (medications and behavior therapy) is
the Multimodal Treatment Study of Children with ADHD (MTA Cooperative Group,
1999a; Arnold et al., 1997a, 1997b; Richters et al., 1995), which is one of the largest
NIMH funded research projects conducted, regardless of diagnosis. The MTA assessed
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the adequacy of 4 treatment groups in decreasing ADHD symptomatology, namely 1)
standardized, careful medication management only (Jensen et al., 2001b; Vitiello et al.,
2001; Greenhill et al., 1996), 2) standardized and manualized behavioral management
only (Wells et al., 2000a; Pelham, 2000; Pelham et al., 1998), 3) a combination of the
two, and 4) standard community care. Initial results reported by the MTA Cooperative
Group (Jensen et al., 2001a) clearly pointed out the superiority of medication
management only over all other groups.
However, a number of follow-up analyses have provided a better picture of which
approach may work best for whom, especially when considering the potential moderators
and mediators of treatment responses (Owens et al., 2003; Wells et al., 2000b; MTA
Cooperative Group, 1999b). The specific aspects of the family, parent, or child
demonstrated to have an impact on response to treatment include parental compliance and
adherence with the treatment and family stress variables (Hinshaw et al., 2000), parent
cognitions (Hoza et al., 2000), SES (Rieppi et al., 2002), severity (Swanson et al., 2001a,
2001b), and comorbidity (Jensen, 2001a). Additionally, a combined treatment approach is
typically what most pediatricians recommend for most children and adolescents. In fact,
the American Academy of Pediatrics (2001) has issued guidelines for the treatment of
ADHD and a combined treatment approach is strongly recommended.
Much of the information that the American Academy of Pediatrics used to create
proposed guidelines was interpreted from information that was generated by the MTA
Cooperative Group. It can be argued that children diagnosed with ADHD and comorbid
conditions would have a need for more intensive interventions due to their multiple
impairments; a combined treatment approach is urgently needed. Therefore, treatment
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must be implemented at home and school, and/or any location where the child may show
impairment. Identifying a comprehensive intervention program which treats ADHD and
comorbidity, regardless of whether the problems are co-occurring internalizing or
externalizing disorders, remains of substantial interest to researchers.
One particular intensive behavioral intervention that uses a combined treatment
approach that merits attention for treating children diagnosed with ADHD is the Summer
Treatment Program (STP), a comprehensive day treatment program. To date, much of the
research focused on the Summer Treatment Program has been conducted by Pelham et
al., (2010). The STP was a critical component of the MTA behavioral management-only
group and has been recognized as a model treatment program for ADHD by the National
Institute of Mental Health for well over 20 years (Pelham & Hoza, 1996; Pelham et al.,
1998). The intensive Summer Treatment Program combines the structure of the schoolyear with an outpatient follow-up program to provide a maximally effective psychosocial
intervention for ADHD (Chronis et al., 2004; Pelham & Hoza, 1996). Yet to date, no
research has fully addressed the potential effectiveness of such an intensive behavior
program with children diagnosed with ADHD and comorbid conditions. Therefore, the
purpose of this dissertation was to examine whether or not the Summer Treatment
Program effectively treats children diagnosed with ADHD and a comorbid condition.
Research Questions
The purpose of this dissertation is to answer the following research questions:
•

Do children diagnosed with ADHD alone, who attend an intensive
summer treatment program, differ in treatment outcomes from those
children diagnosed with ADHD and a comorbid diagnosis?
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•

Do males diagnosed with ADHD and a comorbid diagnosis, who attend an
intensive summer treatment program, differ in treatment outcomes from
females with ADHD comorbidity?

•

Are there age group differences in treatment outcomes with children
diagnosed with ADHD and a comorbid diagnosis who attend an intensive
summer treatment program?

•

Do children with different comorbid diagnoses and ADHD, who attend an
intensive summer treatment program, differ in treatment outcomes?

To begin to answer these research questions, a review of literature was conducted.
Chapter Two provides a look at treatments for ADHD and comorbidity, including
information about: ADHD and comorbid learning disorders, ADHD related to gender and
comorbidity studies, and the MTA Cooperative Group, comorbid subgroups studies,
alternative intervention programs and the summer treatment program
Conclusion
In conclusion, this chapter outlined the historic and clinical foundations of this
dissertation research. Highlighting the foundational studies led to the next research step
of examining the efficacy of the Summer Treatment Program. The research questions
were formed from the identification of the need for further research about treatments with
children diagnosed with ADHD and a comorbid condition. A detailed examination of the
relevant literature follows in Chapter Two.
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CHAPTER II
LITERATURE REVIEW
This chapter reviews relevant literature, including studies’ descriptions and
analyses, to highlight some of the comparable research relating to this current
dissertation. Sections in this chapter include discussions of both contributions and
limitations, concerning the topic of treatment for ADHD and comorbidity, including
information about: ADHD and comorbid learning disorders, ADHD relating to gender
and comorbidity studies, and the Multimodal Treatment Study of Children with ADHD
MTA Cooperative Group, comorbid subgroups studies, alternative intervention programs
and the summer treatment program. The studies discussed in this chapter lead to a better
understanding of how this dissertation research contributes a next step in the vast
literature about ADHD.
Since the 1980s there has been an increase in the number of U.S. children
diagnosed with behavioral and learning disorders (Pastor & Reuben, 2008). Increases in
diagnoses of ADHD cross all socio-demographic lines (Visser et al., 2010). The growing
numbers of children with behavioral and learning disorders have been met with an
expansion of programs and services for children and adolescents.
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Children diagnosed with ADHD often rely on stimulant medication as their only
form of treatment. However, major professional organizations are virtually unanimous in
endorsing the merits of combined medication and behavior therapy (Waschbush, Carrey,
Willoughby, King, & Andrade, 2007). In 1987, the American Academy of Pediatrics
(AAP) restated their earlier position that “Medication for children with attention deficit
disorder should never be used as an isolated treatment,” and went on to describe several
strategies for treating children with ADHD, such as behavior modification, physical
education programs, and “the provision of structure,” in fact recommending that these
strategies should be tried before resorting to medication (AAP, cited in Hoffman, 2009, p.
33). Stimulant medications have since become the first line treatment for ADHD. At the
same time, there is an accumulating evidence base on psychosocial interventions that are
effective for ADHD (Pelham & Fabiano, 2008).
Hoffman (2009) attributed the shift in thinking from behavioral interventions to
reliance on medication to the publication of the Multimodal Treatment Study of Children
with ADHD (MTA) in 1999. Studies reporting findings from the MTA are included in
this chapter (Karpenko, Owens, Evangelista, & Dodds, 2009; MTA Cooperative Group,
2004a, 2004b; Molina et al., 2009; Owens et al., 2003). The more recent research
findings support the assertion that medication is insufficient and that there is a need for a
variety of available treatment options. Pelham and Fabiano (2008) emphasized that
ADHD is a chronic condition and treatment must be both intensive and ongoing. In fact,
Coles et al. (2005) argued that the inconsistent results of behavioral treatments for ADHD
may be attributed to the general reliance on non-intensive interventions.
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Pelham and Fabiano (2008) and Coles et al. (2005) conducted extensive research
on the Summer Treatment Program (STP), detailing the variety of behavioral treatments
in a unique atmosphere of combining recreational and academic activities. Prosocial
behavior was continually rewarded and reinforced by program staff. The STP is also the
focus of this dissertation.
Many of the children who participated in the STP were diagnosed with ADHD
with one or more comorbid disorders, which affected their treatment responses (Coles et
al., 2005). In fact, comorbidity in ADHD is rampant, especially a diagnosis including
ODD (Barnett, Maruff, & Vance, 2008; Efron & Sciberras, 2010; Howe, 2010; Martel,
Gremillion, Roberts, von Eye, & Nigg, 2010; Qian, Cao, Chan, & Wang, 2006).
Children diagnosed with ADHD are also at elevated risk for developing conduct disorder
(Drabick, Gadow, & Sprafkin, 2006). Learning disabilities are also prevalent among
children with ADHD (Jakobson & Kikas, 2002; Miranda, Soriano, Fernandez, Melia,
2008; Pastor & Reuben, 2008; Pelham & Fabiano, 2011). Many children diagnosed with
ADHD also have depression and anxiety in conjunction with externalizing behavior
problems. Further complicating the accurate assessment and treatment of ADHD is the
fact that the symptoms of the coexisting disorders overlap considerably with the
symptoms of ADHD (Rowland, Lesesne, & Abramowitz, 2002).
According to Pelham and Fabiano (2001), the pivotal factor in successfully
treating children diagnosed with ADHD and comorbid conditions is not the diagnosis, per
se, but rather the impairment associated with the comorbid conditions. They emphasized
that ADHD is not solely defined by symptoms; impairment in functioning is typically the
cause of referrals for evaluation and should be the focus of treatment. Karpenko et al.
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(2009) addressed the question of whether clinically significant changes in the symptoms
of ADHD and ODD translate into reliable improvement in psychosocial functioning.
One glaring gap in the research literature is the lack of attention to girls diagnosed
with ADHD (Elkins et al., 2011; Lee & Hinshaw, 2006; Marks, Nichols, Blasey, Kato, &
Huffman, 2002; Monteaux, Mick, Faraone, & Biederman, 2010; Pelham & Fabiano,
2008; Zalecki & Hinshaw, 2004). There is some evidence of a “gender paradox;” that is,
when a disorder is more common in one gender, it may have more negative ramifications
for the gender in which it is less prevalent (Elkins et al., 2011). However, it is impossible
to ascertain whether that is accurate for ADHD without sufficient research on ADHD
diagnoses in girls. Many studies have included only boys and examined individual
variations, which are substantial in the case of ADHD. Beyond gender comparisons,
there is a need for further investigation of individual differences among girls, including
the etiology, manifestations, and treatment of comorbid disorders.
Gender, ADHD and Comorbidity
Rydell (2010) investigated family factors as features related to ADHD and ODD
in a community sample drawn from two areas of Sweden. The random sample of 1,206
10-year old children was 52% male, with the overwhelming majority (93%) of the
children having at least one sibling. Most of the children lived with both biological
parents, whose educational level was fairly high. In addition to sociodemographic
attributes and ADHD and ODD symptomology derived from DSM-IV criteria, the
parents were queried about negative life events affecting the child and the family.
Sociodemographically, the children living in single or stepparent families, whose
mothers had low educational level, and whose families were non-European heritage were
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more likely to display high levels of ADHD and ODD symptoms (Rydell, 2010). It is
questionable whether the effect of ethnicity, which was specifically linked with ODD, is
applicable to the much more diverse U.S. society. Most of the non-Europeans were
immigrant families from the Middle East and many were refugees, which heightens the
stress of immigration. ADHD was strongly linked with residing in a single parent or
stepparent family.
A notable finding was that adverse life events, especially family conflicts,
increased the risk of ADHD and ODD above the effects of sociodemographic factors, but
sociodemographic factors had minimal moderating effects on adverse life events (Rydell,
2010). Boys appeared to be more vulnerable to stress than girls. In view of the strong
biogenetic component of ADHD, Rydell had expected sociodemographic factors to have
less of an effect on ADHD than ODD; however, that was not the case. To Rydell, the
most striking finding was the powerful impact of family stress on the development of
disruptive behavior disorders.
Rydell (2010) observed that teachers, but not necessarily parents, tended to report
a higher prevalence of ODD symptoms in boys compared to girls. Derks, Dolan,
Hudziak, Neale, and Boomsma (2007) questioned whether gender differences in the
prevalence of ADHD and ODD might reflect measurement bias. They also examined
prospective gender differences in the genetic and environmental influences on the two
behavior disorders. The study was part of an ongoing research project on development
and psychopathology involving twins from the Netherlands Twin Registry. The twins
were all from a 1992-1996 birth cohort considered nationally representative at age 3
based on their Child Behavior Checklist (Achenbach, 1991) scores and were later
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assessed by their teachers at age 7 using the Conners Teacher Rating Scale-Revised:
Short Version (Conners, 2001). The sample was composed of 800 male and 851 female
7-year old twins.
The teachers’ assessments of ADHD and ODD behaviors were consistent for boys
and girls, thus showing no indication of bias. Derks et al. (2007) interpreted this finding
as evidence that boys are more susceptible to ADHD and ODD than girls. For boys and
girls more than half the variation in ADHD and ODD was attributable to genetic factors.
However, different genes seem to play a role in the gene expression of ADHD and ODD
in each gender. The study did not explore specific environmental influences on behavior,
except to conclude that the variation in ADHD and ODD, which is not accounted for by
genetic factors, was attributable to unique environmental influences.
Marks et al. (2002) examined behavior problems associated with ADHD
comorbidity in 40 girls diagnosed with ADHD, with 55 boys as a comparison group.
Drawn from children who had been evaluated at a Northern California community
behavioral health center, the children had a mean age of about 9 years and were primarily
white or Latina/o. In addition to DSM-IV or DSM-III-R diagnostic tests, the children
were assessed using the CBCL. There were no significant differences in ADHD subtypes
based on gender. Consistent with the ADHD diagnosis, the girls were rated by their
parents as exhibiting clinically significant levels of attention difficulties, regardless of a
concurrent problem. However, different behavior patterns were found between the girls
diagnosed only with ADHD or had ADHD with comorbid Axis I disorders and those who
had ADHD diagnoses in combination with LD.
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Apart from inattention, the girls diagnosed with ADHD and LD had few
behavioral problems (Marks et al., 2002). Compared to that group, the girls with only
ADHD had significantly elevated scores on the subscales of Delinquent Behavior and
Somatic Complaints and the girls with ADHD and Axis I disorders were assessed by their
parents as displaying more aggressive behavior and somatic complaints. Marks et al.
noted that actually the girls’ scores on the Somatic Complaints subscale were relatively
low compared to other dimensions, but it served the purpose of distinguishing the three
groups of girls: ADHD only, ADHD with Axis I disorders, and ADHD and LD, in
particular the first two groups from the girls with ADHD and LD. Among the boys
diagnosed with ADHD, those with ADHD and LD also had evidence of behavior
problems, which is consistent with most research findings.
Monteaux et al. (2010) investigated the role of gender in the trajectory of ADHD
and comorbid conditions from childhood to adolescence. The participants came from
two longitudinal family studies conducted in Massachusetts. The first study started in the
late 1980s with families who had one boy with ADHD and a male sibling without ADHD
between the ages of 6 and 17 at the onset of the study. The participants were assessed at
4-year and 10-year follow-ups. The second study, using the identical design, involved
girls with ADHD and their female siblings. Monteux et al. combined the data from both
studies, with a total sample of 471 participants with ADHD and a mean age of 11.5 at the
baseline assessment.
For both male and female participants, Monteux et al. (2010) observed a decline
in ADHD symptoms over time, which is commonly reported. However, gender
differences emerged in the effects of age on comorbid conditions. Among the girls,
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psychiatric comorbid diagnoses were relatively stable from childhood to adolescence,
compared to their male counterparts. Additionally, childhood and adolescent ADHD
comorbidity were not associated with adolescent comorbidity among the males, but
among the females, the stability of comorbidity retained its significance even after
accounting for the association between childhood comorbidity and ADHD. In both
childhood and adolescence, the girls displayed significantly higher levels of severity of
ADHD than the boys, providing some support for the gender paradox. However,
Monteux et al. added that while the difference was statistically significant, it was small
and minimally clinically significant. At the same time, they stated that this finding
warrants additional research.
Comorbid psychopathology in childhood was a significant predictor of future
comorbidity in adolescence. However, the differences in the patterns they found in the
male and female participants led Monteaux et al. (2010) to suggest that for males with
ADHD, the persistence of comorbidity in adolescence may be more contingent on the
severity and persistence of ADHD per se, while for females comorbidity in adolescence
may be more of a result of both the persistence of ADHD and the comorbid condition.
Their findings led the researchers to conclude that gender plays a critical role in the
trajectory of ADHD and concurrent psychiatric conditions.
Academic Performance
Biederman et al. (2004) examined the impact of ADHD and deficits in executive
function on children’s academic performance using data drawn from two identically
designed family studies of ADHD. The two studies involved children and adolescents
with or without ADHD between the ages of 6 and 17 at the time of the intake assessment.
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The second assessment was four years later. The data analysis included 121 male
proband (individual or member of the family being studied) participants diagnosed with
ADHD, 103 male control group participants, 138 female proband participants, and 122
female control group participants. The children were given a battery of psychiatric,
psychosocial, cognitive, and neuropsychological assessments.
As predicted, the children and adolescents with ADHD had a higher incidence of
executive function deficits than their control group peers (Biederman et al., 2004). In
addition, among the participants with ADHD, executive function deficits increased the
risk for LD, grade retention, and lower academic achievement. The analyses also showed
that the children and adolescents diagnosed with ADHD and executive function deficits
came from lower SES families than those with ADHD but no executive function deficits.
This finding is consistent with the higher prevalence of concurrent ADHD and LD in
children whose mothers have limited education (Pastor & Reuben, 2008).
Learning Disabilities
Miranda et al. (2008) investigated the impact of age and LD with 67 boys and 5
girls with ADHD. Most were from low SES families. The children were divided into
four groups based on LD status and age: 6-9 years and 10-14 years. The children were
assessed with the Conners' Teacher Rating Scales–Revised: Long (Conners et al., 1998)
and the Strengths and Difficulties Questionnaire (Goodman, 1997). Parents and teachers
both served as behavioral raters. It is not unusual for parents and teachers to diverge in
their ratings of children’s behaviors. There was more congruence between parents and
teachers regarding externalizing behaviors which are more persistent, severe, and overt.
On the more subtle internalizing symptoms of anxiety, emotional liability, and emotional
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problems there was limited agreement between parents and teachers. There is always the
question of whether parents and teachers have different subjective judgments or children
behave differently at home and at school. Both explanations may account for some
degree of discordant ratings.
The children diagnosed with ADHD and LD had more psychological problems
than those with ADHD alone (Miranda et al., 2008). Based on the teachers’ appraisals,
the older children with ADHD had more psychological problems than their younger
counterparts. According to the researchers, the older children may have had unsuccessful
interventions in the past and their symptoms might have escalated. Alternately, there are
more academic demands on children in the higher grades and problems such as
inattention and lack of organization and planning present more of an impediment
academically. Overall, the group with the highest level of problems was the younger
children with ADHD and LD.
Jakobson and Kikas (2007) examined cognitive functioning in children with and
without ADHD diagnoses, with and without LD. The participants were 152 children
ranging in age from 7 to 10 years who were tested individually in private, quiet rooms in
psychiatric hospitals for the clinical group and at school for the non-clinical group. All
the children diagnosed with ADHD had the combined type. There was only one girl in
each of the two clinical groups (ADHD-C plus LD or ADHD-C without LD). Each child
was individually matched on age and gender with a control group child.
The study was conducted by researchers at the University of Tartu in Estonia who
created the tests for the purpose of their study (Jakobson & Kikas, 2007). The children
were presented with five tests of visual-spatial skills, including working memory tasks,
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both verbal and visual-spatial, two tasks to test fine motor skills, and four tests of verbal
ability. The children with ADHD-C, with or without LD, experienced difficulties
performing tasks that demanded complex cognitive organization. Their ability to process
visual information was substantially lower than the control group, though the children
diagnosed with ADHD alone performed better than those with ADHD and LD. On the
working memory tests, the two groups of children diagnosed with ADHD also performed
lower than the control group but comparably with one another. Jakobson and Kikas
(2007) suggested that poor problem solving skills might have caused the lower
performance.
Having a task that was more concrete was helpful for the children with ADHD
alone but not for the children diagnosed with ADHD and LD (Jakobson & Kikas, 2007).
The only task on which ADHD did not impede performance was a fine motor task that
demanded speed rather than accuracy. On the motor task that demanded coordination,
both groups of children diagnosed with ADHD had difficulty, with some slight advantage
for the children with ADHD and LD. Jakobson and Kikas used discriminant function
analysis to determine if the tests could distinguish the children with ADHD-C and LD
and ADHD-C without LD. The tests accurately classified 73.6% of the children. When
the results of cognitive, academic, and psychosocial assessments of children with ADHD
were examined together, it seems improbable that medication could sufficiently address
the multiple impairments they experienced without psychosocial intervention.
Gender and Psychosocial Competence
Thorell and Rydell (2008) explored the associations between social competence
and behavior problems and children’s gender and age in preschool and school-age
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children. Social competence was assessed using the Social Competence Inventory
(Rydell, Hagekull, & Bohlin, 1997). The SCI has two subscales measuring prosocial
orientation (ability to engage in positive peer interactions) and social initiative (ability to
initiate and participate in social interactions). The Strengths and Difficulties
Questionnaire (Goodman, 1997) was utilized to assess negative impact on the child’s
everyday life and family burden related to behavioral and emotional problems. The
sample was comprised of 60 children who scored high on ADHD symptoms and 499
comparison children. Analogous to Rydell’s (2010) study of ADHD and ODD, the
children did not meet the full diagnostic criteria for ADHD.
According to Thorell and Rydell (2008), the major finding was that there was no
main effect for age or group status on the children’s behavior problems. Despite this, the
parents of older children, especially those with high levels ADHD symptoms, reported a
greater negative impact on everyday life and family burden compared to the parents of
younger children. Gender did affect both ADHD and behavior. That is, the boys
exhibited more severe symptoms of ADHD as well as related behavior problems.
Implicitly, the gender differences are consistent with the notion that girls with ADHD are
less likely than boys to display high levels of hyperactivity or impulsivity. However,
Thorell and Rydell emphasized that there were considerable differences in externalizing
behavior and adverse effects of behavior problems between girls with high levels of
ADHD symptoms and the comparison group girls.
Thorell and Rydell (2008) found it especially striking that the preschool children
with high levels of ADHD symptoms had serious behavior problems associated with
ADHD, thereby implying that behavior problems should not be regarded as simply a
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long-term consequence of untreated ADHD. In fact, they are present at a very young age.
The researchers suggested that conceptualizing preschool ADHD as a “highly complex
condition with elevated levels of several different types of comorbid deficits” might be
more conducive to accurate and appropriate diagnosis and treatment (p. 593). This
viewpoint is similar to that of Pelham and Fabiano (2001).
Elkins et al. (2011) included academic performance as one of several
psychosocial domains in their study of the effects of ADHD and gender. Raising the
question of whether there is indeed a “gender paradox” related to ADHD, their main
issue was whether girls and boys diagnosed with ADHD are affected differently in
various dimensions of psychosocial functioning. The participants were drawn from the
Enrichment Study; an extension of the Minnesota Twin Family Study, designed to
provide longitudinal data on children at high risk for adolescent substance abuse as a
result of a childhood disruptive behavior disorder (Keyes et al. 2009). The participants
for the Elkins et al. (2011) study were 520 girls and 478 boys, all 11 years old. The
children were classified into four groups representing the three ADHD subtypes and a
comparison group with no ADHD diagnosis. Clinical interviews disclosed several
childhood disorders in addition to ADHD, including ODD, CD, depression, and
separation anxiety. Measures of academic ability and performance included the
children’s IQ scores, parents’ reports of academic problems and expectations for their
child’s academic success, class GPA, and teachers’ appraisals. Peer relationships were
assessed via the Popularity Scale from the Piers-Harris Self-Concept Scale (Hur, McGue,
& Iacono, 1998) to assess the children’s self-concepts and the teachers’ assessments of
peer relationships.
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The number and severity of ADHD symptoms were comparable for girls and boys
(Elkins et al., 2011). Beyond that commonality, Elkins et al. found a number of
significant differences in the severity of the problems the children experienced based
upon gender and ADHD status or subtype. Compared to their peers without ADHD, the
girls diagnosed with ADHD experienced more adverse effects socially and academically.
A predictable finding was that among ADHD subtypes, girls and boys with the combined
type had the most extensive clinical contact (65.4% and 68.8%, respectively). However,
the decisive factor in the observed “gender paradox” was a diagnosis of the ADHD
inattention subtype. Specifically, girls with the predominately inattentive subtype had
much greater difficulties socially and academically than boys with the same diagnosis.
The girls with predominately inattentive ADHD were especially disadvantaged in
the academic realm, with significantly lower IQ, GPA, academic motivation, and
academic expectations and significantly more academic difficulties than boys with the
same ADHD subtype, as well as compared to girls without ADHD (Elkins et al., 2011).
Socially, the girls with the inattentive subtype were also less popular and more vulnerable
to being picked on or bullied than boys in the same ADHD group. Finding this gender
distinction somewhat curious, Elkins et al. proposed that academic achievement and
social status may be more closely related for girls than boys and therefore academic
underachievement carries more social stigma for girls. Another possible explanation is
that girls are expected to be more attuned and responsive to social cues than boys, and
attention problems interfere with the ability to discern subtle social cues. It seems
probable that both explanations play some role in the social rejection of girls with the
inattention subtype, thus intensifying the magnitude of their social difficulties. Even

32

more ominous for future adjustment, Elkins et al. noted that being bullied raised the risk
of internalizing behavior problems.
The combined ADHD subtype tended to have more negative effects for boys than
girls (Elkins et al., 2011). Boys with the combined subtype were less likely to interact
with prosocial peer role models than girls in the same ADHD group. Additionally,
differences between the children with ADHD combined and their peers without ADHD
tended to be more pronounced for the boys than the girls. The children diagnosed with
the ADHD hyperactive-impulsive subtype, of both genders, had the fewest clinical visits
and were least likely to be on medication, which according to Elkins et al. (2011) could
explain their lower profile in ADHD research. Tzang et al. (2008) had expected their
sample to represent all three ADHD subtypes but none of the children had the H-I
subtype. Among the participants from the Enrichment Study, the boys with the H-I
subtype presented an interesting picture, with high IQs but a significant degree of
externalizing behavior problems and more deviant peers compared to the boys without
ADHD (Elkins et al., 2011). Though they were relatively unimpaired socially as well as
academically, Elkins et al. noted that their preadolescent profile suggested a high risk for
future behavior problems and relational aggression.
In one of the few studies focused exclusively on girls with ADHD, Zalecki and
Hinshaw (2004) explored variations in aggressive behavior among girls with different
ADHD subtypes. The researchers noted that while girls are less likely to exhibit physical
aggression than boys, they tended to be more predisposed toward relational aggression,
defined as “harming others by purposefully damaging or manipulating their peer
relationships, such as by gossiping, spreading rumors, or excluding others from the peer
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group” (p. 126). No researchers had previously examined the nature, prevalence, or
effects of relational aggression in girls with ADHD. Zalecki and Hinshaw (2004)
conducted their research in the natural environment of a summer day camp, though the
participants and staff were all selected for research purposes so that the study would
synthesize “naturalism and rigor” (p. 127). The participants were recruited through a
wide variety of channels, with screening surveys sent out to their parents and teachers.
The research spanned three 5-week summer programs with 79, 77, and 72 girls,
respectively. Most of the girls had never met one another before and the girls diagnosed
with ADHD and the comparison girls interacted together throughout the summer.
Observational data was combined with formal assessments, including behavior
ratings by the camp counselors and peer sociometric nominations (Zalecki & Hinshaw,
2004). Teachers and parents provided assessments of relational aggression. Not
unexpectedly, the girls with ADHD combined subtype were more overtly aggressive than
either the girls diagnosed with ADHD-I or the girls without ADHD. The girls with
ADHD, including both the inattentive and the combined subtype, were rated as showing
higher levels of relational aggression than the girls without ADHD by all informant
groups although there were some distinctions for the two ADHD subgroups. That is,
while the ratings of parents and teachers for relational aggression were equivalent for the
girls with both ADHD subtypes, the counselors and peers perceived much higher levels
of relational aggression in the girls with the combined subtype. This discrepancy
probably reflects differences in the girls’ behaviors in different social settings. The staff
members were most likely to witness the girls interacting informally as well as in sports
and other recreational activities. Zalecki and Hinshaw (2004) also noted that the
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association between relational aggression and positive peer nominations was attenuated
when peer appraisals of relational aggression were excluded from the analyses, thus
attesting to the importance of soliciting peer perceptions to understand subtleties in social
aggression.
In contrast to the findings of Elkins et al. (2011), ADHD-I was less of a social
liability for the girls than ADHD-C, according to Zalecki and Hinshaw (2004). Although
both groups of girls with ADHD were less popular with their peers than the girls without
ADHD; girls with ADHD-I as well as girls without ADHD who displayed aggressions,
either relational or overt, still had peers who wanted to be their friends. That was not true
for aggressive girls with the combined type, who were significantly more disliked and
had few peers who wanted to befriend them. Relational and overt aggression did elicit a
negative response from peers regardless of whether or not the girls had ADHD diagnoses,
but the impact was much more intense for the girls with ADHD-C. Since the study was
conducted, relational aggression has gained more research attention but perhaps due to
the overall dearth of attention to girls diagnosed with ADHD, it is rarely examined in the
context of ADHD.
Lee and Hinshaw (2006) and Owens, Hinshaw, Lee, and Lahey (2009) both
explored psychosocial functioning in adolescent girls with an ADHD diagnosis in followups conducted with girls who had been in the 5-week summer camp research programs.
Lee and Hinshaw (2006) examined childhood ADHD, conduct problems, academic
performance, substance abuse, psychological distress, and peer status in a sample of 140
girls and a comparison group of 88 girls without ADHD who were assessed five years
after the summer program. Hyperactivity-impulsivity was significantly linked with
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conduct problems. This finding, combined with an earlier study led Lee and Hinshaw
(2006) to propose that in girls, hyperactivity-impulsivity may reflect the same trait that
underlies conduct disorder in boys. Noncompliance was also a predictor of conduct
problems while overt aggression, covert antisocial behavior, and peer preferences were
not. The researchers noted that this finding parallels the role of noncompliance in
predicting delinquency in boys over 5 years.
As in the study of Elkins et al. (2011), inattention was associated with poor
academic performance (Lee & Hinshaw, 2006). At the same time, neither antisocial
behavior, hyperactivity-impulsivity, or peer status related to academic performance. The
power of inattention to affect the performance of girls with ADHD in the academic
domain, even after controlling for other factors, led Lee and Hinshaw (2006) to stress the
significance of inattention in the school realm. Only the girls with ADHD had histories
of school suspensions or expulsions during the transition from elementary to secondary
school. Additionally, noncompliance and peer status were independently linked with
behavior problems at school.
In view of evidence that many youths experiment with substance use in
adolescence, Lee and Hinshaw (2006) deliberately chose measures that captured
substance dependence and the range of substances used. Hyperactivity-impulsivity
proved to be the main predictor of substance dependence while noncompliance was
significantly linked with using a variety of different substances. Hyperactivityimpulsivity was also the ADHD symptom most closely linked with internalizing
symptoms. However, the most notable finding, according to the researchers, was the
association of covert antisocial behavior with self-reported depression and of
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noncompliance with internalizing symptoms. Lee and Hinshaw (2006) noted that
internalizing and externalizing symptoms are often found in conjunction in girls, and girls
are more susceptible to depression in adolescence. The range of behaviors included in
the analyses highlighted the different ways in which symptoms of ADHD can manifest in
girls. To Lee and Hinshaw (2006), the detrimental impact of externalizing behavior on
the transition to adolescence underscores the importance of early intervention for ADHD
and associated behavior problems.
Owens et al. (2009) conducted their research with the same sample of 140 girls
with ADHD and 88 comparison girls included in the study of Lee and Hinshaw (2006),
also analyzing the trajectory of ADHD on psychosocial functioning and symptoms
manifestation in a number of psychosocial domains. Among the girls diagnosed with
childhood ADHD, close to 20% had virtually no ADHD symptoms in adolescence.
However, less than half the girls with ADHD scored below the researchers’ criterion for
internalizing problems (49.2%) or externalizing problems (42.1%), while the
overwhelming majority of the comparison girls were below the same threshold (85.2%
for internalizing problems and 91.3% for externalizing problems). More than twice as
many comparison girls, as girls with ADHD, had sufficient social skills (82.7% versus
40.5%). The girls without ADHD also fared better on teacher ratings of social status and
achievement in mathematics and reading.
In total, Owens et al. (2009) explored the participants’ adjustments in adolescence
across six dimensions: ADHD symptoms, externalizing problems, internalizing problems,
social skills, academic performance, and peer acceptance. Between roughly 20% and
65% of the girls with childhood diagnoses of ADHD were positively adjusted with each
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of the six dimensions, but in each dimension the proportion of girls with ADHD was
significantly lower than the proportion of girls without ADHD. In addition, only 16.5%
of the girls with ADHD showed positive adjustment in at least five dimensions compared
to 86.4% of the comparison group. Owens et al. noted that even when psychiatric
symptoms were excluded from the analyses, differences in the positive adjustment of the
ADHD group and the comparison group remained.
Within the ADHD diagnostic categories, Owens et al. (2009) found that the girls
with the inattention subtype fared somewhat less well in positive adjustments than those
with the combined type. Although this finding contrasts with the popular assumption that
the combined type is “worse” than the inattentive type, this pattern is consistent with the
findings of Elkins et al. (2011) for girls diagnosed with ADHD. Owens et al. noted that
there is additional evidence that the inattentive type is linked with negative psychosocial
functioning and the symptoms of inattention are less likely to disappear over time. One
area in which Owens et al. called for further research was in identifying the factors
associated with positive adjustment which may allow for the early detection of children
who are least likely to “grow out of” their symptoms as they mature. They also called for
the development of appropriate interventions.
Medication Treatment and Comorbidity
Ter-Stepanian et al. (2010) investigated the influence of comorbid disorders on
the course of response to medication with methylphenidate in children diagnosed with
ADHD. The research, conducted at the Douglas Mental Health University Institute in
Montreal, took the form of a randomized, double blind, placebo controlled 2 week
crossover trial of stimulant medication involving 267 children with ADHD ranging in age
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from 6 to 12 years. Parents’ and teachers’ ratings were used in conjunction with clinical
assessments. More than 80% of the children were diagnosed with one or more comorbid
psychiatric disorders. Close to half (47.2%) of the children met diagnostic criteria for
anxiety, 40.8% for ODD, 27.7% for CD, and 7.9% for depressive disorders. More than
one-third of the children had comorbid ADHD and ODD or CD and an anxiety or
depressive disorder. Boys predominated (77.9%) and a sizable proportion of the
participants came from economically disadvantaged families.
According to Ter-Stepanian et al. (2010), the degree of comorbidity in their
sample highlighted the complex clinical symptomology of children with ADHD. More
than one-third of the children were referred by the Severe Disruptive Disorders Program,
which included a day hospital. The presence of multiple comorbidities did not weaken
the effect of the stimulant medication, but there were differences in medication responses
contingent on the specific disorder. The children diagnosed with ADHD and ODD or CD
tended to respond favorably to medication according to parent and teacher reports.
Stimulant medication directly and indirectly affected the disruptive behavior the children
displayed. At the same time, changes in the behavior of children with these disorders
was easily detectable to observers and those with whom the children interact, which
could account for some degree of the high response rate.
In contrast to the positive impact of medication on the children with comorbid
ODD and CD, the presence of an anxiety disorder decreased the effectiveness of
methylphenidate. Ter-Stepanian et al. (2010) suggested that cognitive behavior therapy
(CBT) combined with medication would be an effective treatment for children with
comorbid ADHD and anxiety. Van der Oord, Prins, Oosterlann, and Emmelkamp (2007)
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also suggested that children with comorbid ADHD and anxiety might benefit from CBT
intervention. There own study found no support for the assumption that children with
ADHD taking an optimum dosage of stimulant medication would gain additional benefits
from behavioral interventions. However, they emphasized treatment must be tailored to
each child’s individual needs. Children from low-income families tended to respond well
to the medication and indeed, low-income children with ADHD tended to use stimulant
medications at higher than average rates (Ter-Stepanian et al., 2010). Genetic and
environmental factors may play a role in the treatment response.
Faber et al. (2010) explored the treatment patterns of children diagnosed with
ADHD in the Netherlands with emphasis on the use of stimulant medication and the
presence of comorbid disorders. Children under 16 taking stimulant medication for
ADHD were identified from the records of pharmacies and the researchers sent
questionnaires to the prescribing physicians. The survey produced 510 completed
questionnaires, with 31% of the children having one or more comorbid psychiatric
conditions. The most prevalent comorbid condition was pervasive developmental
disorder (10.4%), which is unusual in U.S. research on ADHD. In fact, the overall rate of
comorbidity was low. Additional comorbid diagnoses included ODD or CD (9.8%) and
LD (5.5%), with small numbers of children diagnosed with mental retardation, tic
disorder, and anxiety disorder.
According to the physician reports, the children diagnosed with ADHD and
comorbid conditions were more likely than those with ADHD alone to be involved in
psychosocial interventions in conjunction with medication. They were also more likely
to be taking psychotropic medications as well as stimulant medications, which Faber et
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al. (2010) attributed to the number of children with PDD. They also suggested that the
number of children participating in psychosocial interventions might be underestimated
because the physicians might have been unaware of them. Combined medication and
psychosocial treatment was generally recommended for children with ADHD and in
particular, for children with ADHD and comorbid disorders.
Oppositional defiant disorder. Research has shown that children with comorbid
ADHD and ODD respond favorably to the combination of counseling and psychotropic
medication (Biederman et al., 2007). The cornerstone of medication treatment for
ADHD and ODD generally involves treating the symptoms of poor impulse control,
anger and irritability with stimulate medications such as methylephenidate. Additional
classes of medication have also been shown to be effective in treating comorbid ADHD
and ODD including atypical agents (aripiprazole) antidepressants (fluoxetine) and beta
blockers (atomoxetine). Of the previously mentioned classes of medication, there is far
less research on the use of atomoxetine for treating children with ADHD than the
extensive body of research on methylphenidate. In addition, there is limited research on
atomoxetine for treating comorbid ADHD and ODD (Biederman et al., 2007).
Biederman et al. presented a meta-analysis of the results of three randomized, double
blind, placebo controlled trials of children and youth between the ages of 6 and 16. The
participants received either a placebo or atomoxetine every day for 6 to 8 weeks. Out of
512 participants, 158 were diagnosed with comorbid ADHD and ODD. Compared to the
placebo, atomoxetine resulted in a significant decrease in ADHD symptoms regardless of
the presence or absence of ODD. Additionally, the medication treatment produced
significant improvements on most dimensions of psychosocial functioning in the children
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with ADHD only and comorbid ADHD and ODD. In fact, the decrease in ODD
symptoms was heavily dependent upon the intensity of the ADHD response. The overall
findings confirmed that the presence of ODD did not interfere with the children’s
response to atomoxetine.
Callous and unemotional traits. Waschbush et al. (2007) investigated the
effects of behavior modification with and without methylphenidate medication in
children with ADHD and conduct problems, including the prospective role of callous and
unemotional traits on the children’s academic and social competence. There is some
evidence that callous and unemotional traits, such as lack of empathy and remorse,
heighten the risk for future antisocial behavior in children with conduct problems. Early
onset conduct disorders often occur in conjunction with ADHD and the behavior of
children with conduct problems can be considerably different depending upon the
presence of callous and unemotional traits. Prior to this study, there was considerable
disagreement regarding whether this affects a child’s response to behavioral
interventions, and no previous research had examined the effects of stimulant medication
on children with ADHD and conduct problems (CP) with and without callous and
unemotional (CU) traits.
The participants in the study by Waschbush et al. (2007) were 29 boys and 8 girls
with an age range from 7.24 to 12.53 years who had attended the Summer Treatment
Program (STP). All the participants had diagnoses of ADHD-C (combined type) in
conjunction with either ODD (43.2%) or CD (56.8%). Callous and unemotional (CU)
traits were assessed on the basis of parent and teacher ratings using the Antisocial Process
Screening Device (Frick & Hare, 2001). Nineteen of the children scored below the cut-
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off point and 18 scored above the cut-off and were designated the ADHD/CP-CU
(conduct problems and callous and unemotional) group. All of the children participated
in the STP activities which included behavioral feedback. The medication regimen
utilized an individualized within-subject, placebo controlled format. After an initial 2week baseline period, each child was involved in a 6-week medication assessment to test
the effects of the placebo. Medication was assigned randomly and due to absences, there
were individual differences in the number of days the children received low dose or high
dose medications or a placebo, but there were no differences in the average medication
days or dosage according to group (ADHD/CP-only or ADHD/CP/CU).
The findings demonstrated that when the children received behavior therapy
without medication, those who had callous and emotional traits in additional to ADHD
and conduct problems displayed more antisocial behavior than their peers with ADHD
and conduct problems alone (Waschbusch et al., 2007). The group distinctions that
emerged centered mainly on conduct problems, rule following, and noncompliance rather
than on behaviors such as classroom seatwork, helping and sharing or on ADHD
symptoms such as disruptive behavior. While acknowledging that the reason for this
pattern is uncertain, Waschbusch et al. proposed that results may have reflected
differences in the baseline prevalence of antisocial behaviors. In other words, children
with callous and emotional traits initially had markedly higher levels of antisocial
behavior, which behavior therapy alone was inadequate to change. Another prospective
explanation was that children with callous and emotional traits reacted differently to
behavioral reinforcements.
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Notably, the group differences decreased dramatically when the children took
stimulant medication in addition to participating in behavior therapy (Waschbusch et al.,
2007). In fact, the responses of the children to the stimulant medication surpassed the
expectations of the researchers, who expected their medication responses to be less
pronounced than the children with ADHD and conduct problems only. There is some
controversy on the question of whether the reduction of impulsivity allows children with
antisocial tendencies to engage in more planned antisocial behavior, but that did not turn
out to be the case. At the same time, Waschbusch et al. acknowledged that the
assessment tool they used was not sensitive enough to discern whether the antisocial
behavior was planned or unplanned. There was some evidence that stimulant medication
may have decreased some manifestations of antisocial behavior but increased others.
Waschbusch et. al also noted that while there were few significant group differences,
individual differences between participants suggested that overall, treatment was less
likely to normalize the behavior of children who displayed callous and emotional traits in
addition to ADHD and conduct problems.
Psychosocial ADHD Treatments
Pelham and Fabiano (2008) built on a research review conducted by Pelham,
Wheeler, and Chronis (1998) examining evidence-based psychosocial interventions for
children with emotional and behavioral disorders (EBD). The original research review
produced several conclusions. First, behavioral parent training marginally met criteria
for well-established treatment, but it did meet criteria for a probably efficacious
treatment. Second, classroom behavior contingency management had an extensive
evidence base. Third, there was additional support for classroom interventions found in
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studies conducted before DSM-III became widely used, documenting the effectiveness of
behavior modification for children with inattention or disruptive behaviors although not
formally diagnosed with ADHD. Fourth, there was insufficient evidence in support of
social skills training or other peer interventions. Fifth and finally, there was no empirical
support for cognitive interventions for children with ADHD.
In view of the upsurge in research on psychosocial treatments for ADHD since
1998, Pelham and Fabiano (2008) examined studies that had been conducted since the
original research review. The empirical evidence bolstered support for the effectiveness
of behavioral parent training, and behavior contingency management, and also
documented the effectiveness of intensive, peer oriented behavioral programs conducted
in recreational environment such as summer programs. The overarching conclusion was
that ADHD is a chronic disorder and therefore it is misguided to believe that a “brief,
time-limited [original emphasis] treatment regimen” regardless of its nature would be
“sufficient and effective” for treating children with ADHD (p. 209). Pelham and Fabiano
(2008) emphasized that most children with ADHD will require prolonged “chronic,
intensive, pervasive, palatable treatment that promotes engagement and adherence” (p.
210).
Reeves and Anthony (2009) outlined several benefits of employing multimodal
treatment rather than medication alone for children and adolescents with mental health
disorders. First, psychosocial interventions offer an opportunity for parents to be actively
involved in their child’s treatment and to learn parenting skills that can have a positive
impact on other siblings, as well as the target child. Second, medications may address
disease-specific symptoms, but not the full scope of “symptoms-related” problems such
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as impaired family or peer relationships, ability to cope with stress, or entrenched
aggressive behaviors. Essentially, this corresponds to Pelham and Fabiano’s (2001) call
to treat impairments rather than symptoms. Both sources agree that psychosocial
treatments can have a powerful impact on child and family functioning that may decrease
the need for medication. Third, the time spent engaged in psychosocial interventions can
mean more time for support and time for the clinician to assess a child’s safety in areas
such as suicidal feelings or child abuse (Reeves & Anthony, 2008). Multimodal therapy
also allows clinicians more time to spend with parents discussing medication issues as
well as the child’s overall treatment.
Multimodal Treatment Study of ADHD
The Multimodal Treatment Study of ADHD (MTA) was a randomized clinical
trial sponsored by the National Institute of Mental Health (NIMH) and conducted at 6
sites (MTA Cooperative Group, 2004a). A sample of 597 children diagnosed with
ADHD combined type between the ages of 7 and 10 were randomly assigned to 1 of 4
modes of therapy: medication management, behavior modification, combined medication
management and behavior modification, and routine care community treatment. At the
end of the initial 14-month treatment phase, all four groups of children displayed
substantial improvements, though some differences were observed. Medication
management and combined therapy were both more successful in treating ADHD
symptoms than behavior management alone or routine community care. On subjective
assessments, the combined treatment was superior to all three of the other treatments
based on oppositional and aggressive and internalizing symptoms reported by parents’
and teachers’ assessments of social skills, parent child relationships, and reading
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performance. While two-thirds of the children receiving community treatment were
taking medication, the intensive MTA medication regimen proved more effective.
The researchers attempted to identify characteristics that would predict the
children’s responses. However, rather than predictors they found moderators in
treatment response (Owens et al., 2003). Specifically, medication management and
combined treatment were linked with lower rates of “excellent response,” defined as the
reduction of ADHD and ODD symptoms to a level at or near the normal range in children
who began the study with extremely severe ADHD symptoms or had depressive
symptoms according to parents’ reports. Excellent response rates were particularly low
when the child also had an IQ below 99. None of the characteristics examined moderated
the effects of behavior therapy alone or community care treatment.
A critical point for the MTA was whether the treatments would have enduring
effects. The first follow-up was conducted at 24 months, with data from 540 children
(MTA Cooperative Group, 2004a). The follow-up affirmed the superiority of the MTA
medication management and the combined medication management and behavior
modification over behavior modification alone and routine community care. However,
the effect size was only half as large after 24 months than at 14 months for both ADHD
and ODD. Consistent but non-significant effects were observed for the superiority of the
combined treatment over intensive medication management alone on measures of ODD
symptoms, social skills, and parental discipline, along with overall normal adjustment.
This pattern reflected similar findings at 14 months.
According to the researchers, the finding suggested that the high dosage of
medication used by the medication management and combined MTA groups provided an
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early advantage that lingered even if the children stopped taking the medication after 14
months (MTA Cooperative Group, 2004a). Nevertheless, the effects of intensive
medication management dissipated over time. Though non-significant in the quantitative
analysis, the behavior modification techniques appeared to have given a social advantage
to the children in the combined group that extended beyond the effects of ADHD
symptom reduction.
The MTA researchers also examined the effects of the intensive medication
regimen on the growth of the children, which also entailed a more detailed analysis of the
dosage and maintenance of the stimulant medication (MTA Cooperative Group, 2004b).
The analysis suggested that the decline in effectiveness during the follow-up stage might
have been due to a reduction in medication as opposed to a decrease in effectiveness of
the stimulant medication over time. According to the researchers, this explanation is
consistent with the prevalent viewpoint that stimulant medication effectively treats
symptoms of ADHD, but it does not have enduring effects once the medication is
stopped. On the other hand, while behavior modification had a less powerful impact than
medication, it can produce lasting benefits if the behavior is generalized and reinforced.
The researchers were somewhat surprised by the number of children in the
medication management and combined treatment groups who stopped taking stimulant
medication after the study and the number of children in the behavior modification group
who did not take medication (MTA Cooperative Group, 2004b). However, while
clinicians may find this counterintuitive, the parents’ reports of satisfaction with
treatment revealed that the parents in the behavior management group were more
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satisfied with treatment than those in the medication management group and reported
equivalent improvements despite the objective differences in symptom reduction.
There is no clear understanding of how treatment preferences and availability
influence the treatment planning of families of children diagnosed with ADHD
(Brinkman & Epstein, 2011). Brinkman and Epstein conducted a research review on the
topic, which disclosed a number of factors that influenced the initial decision in choosing
treatment after the child’s ADHD diagnosis. The family’s beliefs about the nature of the
child’s disorder play a major role in the choice of treatment, along with the information—
or misinformation—they acquired from various sources. Over time, their treatment
preferences were shaped by their own experiences with different therapeutic modalities,
and whether or not treatment plans were continually reassessed and revised. As
described by Brinkman and Epstein, the process entailed an ongoing cost-benefit analysis
in which the family works with their health care team to create a treatment plan that
maximizes the benefits to the child and minimizes detrimental effects and costs.
Undesirable side effects are often the cause for individuals to stop taking
medication even when it helps the condition for which it is prescribed. The MTA
researchers acknowledged that their evaluation of treatment effectiveness did not include
ratings of medication side effects, tolerance, adaptive functioning, or quality of life,
which are important elements of subjective satisfaction with treatment (MTA
Cooperative Group, 2004b). The one medication side effect that was examined as part of
the MTA was possible growth suppression from taking stimulant medication. There was
some evidence of this phenomenon in that the children who continually took medication
grew at a somewhat slower rate than those taking no medication. At the same time, there
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could be other factors affecting the children’s growth. The researchers emphasized that
there is no way to predict how medication would affect the eventual size of preadolescent
children. In addition, they pointed out that stimulant medication did not seem to affect
the adult height of the now adult participants in studies of ADHD medication conducted
in the 1970s.
Karpenko et al. (2009) investigated the relationship between clinically significant
changes in the symptoms of ADHD and ODD and reliable improvement in psychosocial
functioning across multiple domains among MTA participants. The analysis was based
on 417 children using data from baseline and 14-month assessments. The results
demonstrated that the children who experienced clinical changes in ADHD and ODD
symptoms had a significantly higher probability, than those with no clinical changes, to
enjoy reliable improvements on 6 out of 9 psychosocial indices.
An intriguing finding, however, was that 14% to 52% of the children who did not
display clinically significant change also showed reliable psychosocial improvement,
depending upon the particular domain (Karenko et al., 2009). The most marked
improvements were in the areas of parent-rated social competence (52%), teacher-rated
social competence (49%), and homework (45%). In addition, 35% showed
improvements in the pervasiveness and severity of their attention difficulties at home.
Karpenko et al. acknowledged that these positive changes might be more meaningful for
parents and teachers than changes in the clinical symptoms of ADHD and ODD. There is
often a discrepancy in the perceptions of parents, teachers, and clinicians.
Comprehensive instruments that are able to capture the full spectrum of behaviors
associated with ADHD would provide a more multifaceted portrait of change that occurs
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with treatment. De Los Reyes and Kazdin (2006) created a Range of Possible Changes
Model encompassing multiple outcome measures, multiple informants, and multiple
analytic strategies. Karpenko et al. recommended future research using the model.
Molina et al. (2009) presented recent findings from the MTA when the
participants were assessed 6 years and 8 years after the initial study. For the most part,
the analyses included the same variables that were used in the earlier MTA reports and
extended them into the domains of adolescent functioning. The measures included
parents’ and teachers’ assessments of ADHD and ODD symptoms, aggression and
conduct; parent and youth reports of delinquent behavior, contact with the juvenile justice
system; parents’ assessments of functional impairments; self-reported depression and
anxiety symptoms; various measures of school functioning and academic performance;
social competence; psychiatric hospitalizations; and driving accidents or citations for
those old enough.
The participants’ randomized treatment groups, when they entered the study, had
no major impact on their ADHD and psychosocial trajectories, but the course of ADHD
symptoms in childhood emerged as a powerful predictor of adolescent outcomes after 6
and 8 years (Molina et al., 2009). Overall, while there was general improvement from
the time of the study, the participants with ADHD still fared less well over time than the
classmate comparison group that entered the study at the time of the 24-month
assessment. The psychosocial and symptom profiles of the participants when they began
the study were the key predictors of functioning in mid or late adolescence. These factors
included the degree of ADHD symptoms severity, intellect, conduct problems, social
competence, and the magnitude of the initial responses to ADHD treatment rather than
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the type of treatment per se. The most favorable outcomes were found for participants
who entered the study with lower symptoms severity, fewer conduct problems or learning
problems, higher IQs and social skills, and families that were more stable and more
affluent. These participants also had the most marked and enduring declines in ADHD
symptoms at 36 months.
Some of the participants continued to take medication 6 or 8 years after they
entered the MTA, but the only advantage medication seemed to offer was for
mathematics achievement (Molina et al., 2009). While 30% of the participants no longer
met DSM-IV criteria for ADHD, Molina et al. were skeptical of whether the criteria may
be too stringent to capture manifestations of ADHD in adolescence and adulthood. Their
overarching conclusion was that there is an urgent need for devising treatments that are
effective, accessible and with lasting benefits, for teenagers diagnosed with ADHD and
their families. They also noted that adherence to ADHD medication tends to decline
drastically with the onset of adolescence. One recommendation is to encourage youth to
participate periodically in psychosocial interventions, a strategy that has some empirical
evidence. For this practice to become more prevalent there must be an accompanying
effort to develop developmentally appropriate, engaging interventions for adolescents.
MTA Study: Comparing Subgroups
Another study which has emerged from the large, controlled clinical MTA study
addressed whether ADHD with co-existing comorbidities should constitute separate
clinical entities. Drawing upon cross-sectional and longitudinal information, Jensen et al.
(2001a) studied 579 children who were assigned randomly to one of four groups, based
on the presence of comorbid conditions: ADHD alone; ADHD with an anxiety disorder;
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ADHD with either oppositional defiant disorder or conduct disorder; and ADHD with
both an anxiety disorder and either oppositional defiant disorder or conduct disorder. This
division of the participants revealed that the relative effectiveness of the different
treatments depended on the condition of the children. Participants diagnosed with ADHD
and anxiety responded equally well to all three experimental conditions – medication
alone, behavioral alone, or the combination. The ADHD-only and ADHD plus conduct
problems groups responded only to treatments including medication. The group with all
three conditions appeared to derive substantially greater benefits from combination
interventions compared with all other treatments (Jensen et al., 2001a).
The Jensen et al. (2001a) findings are very important, partly because of the
implications for understanding and treating ADHD in children and partly because they
illustrate the importance of conducting analyses in which the subjects are disaggregated
and not viewed as if they were a homogeneous entity. This type of analysis allows
researchers to determine how to best match treatments with characteristics of individuals.
The Jensen et al. (2001a) study gave us a better understanding for making a case to
consider differing ADHD classifications across ADHD subtypes.
Alternative Intervention Programs
Few research studies have investigated the efficacy of intensive intervention
programs for children suffering with ADHD and the presence of comorbid conditions.
Barkley et al. (2000) studied annual screenings of 158 preschool children with ADHD
symptoms including aggressiveness, hyperactivity, impulsivity and inattention behaviors.
Children were randomly assigned to one of four treatment groups for the entire school
year: 1) no treatment, 2) parent training only, 3) full-day treatment classroom only, or 4)
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the combination of parent training with classroom treatment. Their findings suggested
that “when parent training is offered at school registration to parents of disruptive
children identified through a brief school registration screening, it may not be a useful
approach to treating children in home and the community…most treatment effects were
specific to the school environment and did not affect achievement skills” (p. 319).
August, Realmuto, Hektner, and Bloomquist (2004) studied elementary school
children with early onset aggressive behavior. The program that they studied was called
The Early Risers Program. This program featured 4 CORE components: a) an annual 6
week summer school program b) a teacher consultation and student mentoring program,
c) child social skills groups, and d) parent education and skills training groups. August et
al. (2004) found children participating in the program showed significant improvement in
academic achievement and school behaviors. Results showed that both girls and boys had
similar treatment responses.
Goossensen, Glind, Carpentier, Wijsen, Duin and Kooij (2006) studied an
intervention program for inpatients diagnoses with both ADHD and substance use
disorders (SUD). Although the sample consisted of adults, the research investigated an
intervention program for screening, diagnosis and treatment of ADHD in patients with
SUD. Just as there is a lack of intervention programs for children with ADHD and
comorbidity, Goossensen et al. (2006) reported the comorbidity of attention deficit
hyperactivity disorder is frequently not well recognized in substance abuse treatment and
that ADHD comorbidity treatment is lacking. Results from their study found the
intervention program: “1) feasible to implement, 2) more than 20% of new patients
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screened positive, and 3) 60% of those patients met criteria for ADHD” (p.259). Further
research was encouraged to address substance abuse treatment with comorbid ADHD.
Summer Treatment Program
One treatment program, the Summer Treatment Program, which provides
treatment for children diagnosed with ADHD has not yet generated much research that
considers the treatment of ADHD with comorbid disorders. The intensive Summer
Treatment Program uses a variety of evidenced-based strategies across academic and
behavioral settings (Coles et al., 2005). The program is based on a token economy in
which the children earn points for appropriate behaviors and lose points if they behave
inappropriately. Although the format is not unusual for a behavior modification program,
the STP strands out for its fusion of recreational and academic activities with therapeutic
treatment. Serious behavior transgressions (such as intentional aggression, intentional
destruction of property, and repeated noncompliance) are met with a time out.
Conversely, the staff members continually reinforce positive social behavior with praise.
Classroom instruction includes seatwork, peer tutoring, technology instruction, and art.
The children are given daily report cards on which the clinical staff members establish
each child’s individual target behaviors and goals for recreational and academic
activities. The parents attend weekly training sessions where they learn how to reinforce
and reward prosocial behavior based on the daily report card performance. In addition,
the counselors hold social skills training sessions each morning and reinforce the exercise
of appropriate social skills throughout the day and weekly parent training are held. The
program is further outlined in detail in Chapter Three.
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When the standardized behavioral therapy is inadequate for inducing positive
behavioral change, the child is given an individually tailored behavior program targeting
his or her specific problem areas (Coles et al., 2005). For evaluation purposes, the
behavior modification protocols were suspended for two weeks. During that time, the
atmosphere reverted to a more typical summer camp, and the children went on trips or
used other privileges they earned. Negative behavior was halted only when it became
disruptive or threatening to others.
Coles et al. (2005) focused on four children, 3 boys and 1 girl, each one with
different behavior patterns. All four children enjoyed substantial improvements in
behavior, though there were some differences according to the settings where the
behavior change was most evident. The study design allowed the researchers to
distinguish individual program effects and evaluate the overall program success at the
same time. For example, one boy had marked improvements in recreational activities but
fewer improvements in the academic setting while for another boy the effects were
reversed. It is noteworthy that the boy who fared well in the recreational setting had a
relatively low IQ which made it harder for him to transfer behavior from a formal to an
informal environment.
Unlike the inconsistent patterns exhibited by the two boys, the girl showed
decisive benefits from the program across different settings. She had comorbid ODD and
an above average IQ (the highest of the four children). Three of the four children were
diagnosed with ODD and one boy was diagnosed with CD. Coles et al. (2005) stressed
that the children had differences in comorbid disorders, internalizing versus externalizing
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behaviors, intellect, medication treatment, and other characteristics. Overall, the four
children made meaningful and substantial gains in behaviors.
Pelham et al. (2002) examined the effects of stimulant medication
(methylphenidate) and expectancy on the behavior, academic performance, and
attributions of 136 boys attending the STP over four summers. Expectancy conditions
were established by manipulating the children’s beliefs of whether they were taking a
stimulant pill or placebo. The design was a within-subject, balanced placebo with daily
crossovers among four conditions (accurately told placebo, placebo received real
medication, real medication but told placebo, accurately told real medication).
The results of the experiment showed that taking a low dose of stimulant
medication produced improvements in the boys’ behaviors and substantially increased the
probability that they would meet their behavioral goals (Pelham et al., 2002). Expectancy
about medication had an influence on their predictions for success that day but it did not
affect their behavior. The boys made stronger internal than external attributions for
success but were adamant in denying internal causes for failure. Taking the stimulant
medication improved the boys’ behaviors on nearly all dimensions in both recreational
and academic environments as well as helping them reach their behavioral goals.
A second experiment examined whether the results Pelham et al. (2002) observed
in the STP would be generalized to the natural classroom environment. The study took
place with 110 of the 136 boys during the school year in their regular classrooms. Apart
from the medication protocol and the daily report card used in the STP, there were no
changes made to the natural setting. The medication effects and attributions paralleled
those observed in the structured STP setting. There was clear and compelling evidence
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of the positive impact of stimulant medication and no evidence that the children felt that
their success was dependent on medication rather than their control of their own
behavior. According to Pelham et al. it was important that the children did not feel
unduly dependent on mediation but at the same time, if they felt medication did not affect
they behavior, they may decide to stop taking it, which is often the case among
adolescents (Molina et al., 2009). Overall, Pelham et al. (2002) viewed the effects of
medication on behavior as highly positive. The children’s successes imbued them with
confidence, which served as further motivation for prosocial behavior.
Fabiano et al. (2007) explored the effects of varying intensities of
methylphenidate and behavior modification with 44 boys and 4 girls attending the STP.
For each type of treatment the intensity was high, low, or no treatment. Behavior
modification treatment was varied in blocks of 3 weeks, with the order randomly
assigned by group. The medication varied on a daily basis and was randomly assigned
for each child. The study focused on classroom behaviors, using the standard STP
behavioral protocols. The results affirmed the effectiveness of medication and behavior
modification independently and combined. Fabiano et al. also noted that a low dose of
medication (0.15 mg/kg) was sufficient to produce a dramatic increase in academic
productivity and increasing the dose resulted in no more than modest increases. The
standard dose of methylphenidate is usually twice as high.
Low intensity behavior modification was as effective as the other interventions
with the exception of the highest medication dose or a combination of high intensity
behavior modification and medication (Fabiano et al., 2007). According to Fabiano et al.,
the key implication of their findings was that children taking high doses of stimulant
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medication may be able to decrease the dosage, or possibly the need for medication, if the
teacher implements behavior modification techniques in the classroom. They suggested
that parents work with teachers to develop a plan and that doctors and school mental
health professionals involved with medication trials should routinely survey the
effectiveness and extent of behavior modification practices, which can be successfully
implemented in most classrooms.
Pariseau et al. (2010) examined whether having additional time would improve
the performance of children with ADHD on academic assignments in a group of 33
children attending the 2007 STP. According to the researchers, the provision of extra
time may actually be counterproductive for children with ADHD, who have difficulty
with sustained attention. The study took place during afternoon seatwork when the
children were working on three assignments: math fluency workbooks, a reading
exercise, and a writing exercise. The children had either 30 minutes or 45 minutes to
finish their assignments. The results, which were based on accuracy and rule following
during the assignment, confirmed the theory that extended time is not helpful for children
with ADHD. Notably, the children’s work was more accurate when they had to complete
it within the shorter time period. Pariseau et al. added that the behavior modification
strategies used in the STP might have allowed the children to complete more accurate
work during the standard time period. Given that children with ADHD have to
participate in high-stakes assessments and an important treatment goal is to improve
academic performance, children with ADHD need strategies that are proven with that
specific population.
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Lopez-Williams et al. (2005) examined the role of athletic performance and social
behavior in the social acceptance of 63 children with ADHD enrolled in the STP.
Recreational activities were an important feature of the summer program and included
skills training in soccer, basketball, baseball, and swimming. For the purpose of the
study, the researchers focused on two types of athleticism: general athletic performance
and performance in a specific sport. Standardized performance measures were developed
by several researchers working together. Social behavior was assessed and recorded
continually throughout the program. Peer nominations and sociometric ratings were used
to assess peer acceptance.
Both athletic performance and social behavior proved to be significant factors in
the social acceptance of children with ADHD. Lopez-Williams et al. (2005) noted that in
general, athleticism is an important dimension of children’s social worlds; therefore it is
not surprising that it should affect the social behavior of children with ADHD. The more
athletic the children according to the measures used for the study, the more popular the
child was likely to be with the group, the more likely to be nominated as a best friend,
and the less likely to face rejection. Negative social behavior was also a powerful
predictor of acceptance but in the opposite direction; in short, negative behavior was
linked with social rejection and the more negative behavior the more likely the child was
to be rejected by peers. On the other hand, positive behavior made others want to
befriend the child. One aspect of the association between athletic performance and social
acceptance that Lopez-Williams et al. did not address was the impact that ADHD
symptoms had on athletic performance. While athletic children may generally be
popular, children who excel in structured athletic activities would be unlikely to exhibit
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disruptive behaviors that interfere with the game or meet. That is, an additional reason
why children who perform well in sports may be popular with peers is that they are able
to control their behaviors. This proposed association between social behavior and
athletic performance may have been captured by the behavioral observations at the STP,
though it was not explicit. The STP program is further outlined in detail in Chapter 3.
Conclusion
ADHD has been identified as one of the most common reasons for referral to
professionals who care for children’s mental health, health, and educational needs
(Anastopoulos & Farley, 2003; Pelham & Waschbusch, 2004), and it is often
accompanied by comorbid disorders, notably ODD, CD, LD, anxiety, and depression.
Pharmacological treatment with stimulant medication has emerged as the first line
treatment for children with ADHD. However, medication does not produce lasting
effects (Molina et al., 2009). Furthermore, medication alone may only address the
specific symptoms of ADHD and still leave children with psychosocial problems that
disadvantage them socially and academically. In addition, the customary high doses may
have unpleasant side effects. There is a growing body of empirical evidence supporting
the effectiveness of psychosocial interventions for children with ADHD (Pelham &
Fabiano, 2001, 2008). Through the involvement of parents, teachers, other important
adults, and peers, children diagnosed with ADHD learn to master prosocial skills,
providing they are continually reinforced. Behavioral treatment plans can be
individualized to each child’s needs, which is important given the numerous individual
variations. The critical issue is that the target behavior must be continually reinforced in
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the natural environment. The most effective therapy for children diagnosed with ADHD
may be multimodal, intensive, sustained, and individualized.
In conclusion, there is substantial existent literature examining both treatment and
intervention programs for those diagnosed with ADHD and learning disabilities,
internalizing and externalizing disorders and substance abuse. However, there is an
absence of research that examines the effectiveness of comprehensive intervention
programs for the treatment of ADHD with other comorbid conditions. Specifically, a
review of the literature found no studies or programs suggesting children from differing
age groups, gender or comorbid diagnoses benefit from an intensive comprehensive
intervention program such as the Summer Treatment Program. Therefore, this
dissertation research is intended to gain more knowledge about children diagnosed with
ADHD and a comorbid diagnosis. The next chapter describes the study’s participants,
the data collection procedures within the Summer Treatment Program (STP),
instrumentation, and the research design including limitations of analyzing the data,
research questions, and a statistical plan and analysis of data.
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CHAPTER III
METHODOLOGY
Introduction
The description of the methodology, in this chapter, is divided into four sections.
First, the characteristics of the study’s participants are discussed. The second section
presents the data collection procedures within the Summer Treatment Program (STP).
Third, the instrumentation is discussed. Lastly, the research design including limitations
of analyzing the data, hypothesis, and a statistical plan and analysis of data is detailed.
Data Source
This research was based on archived data from 1999 - 2012 retrieved from the
Summer Treatment Program implemented through an ADHD behavioral clinic of a large,
metropolitan children’s hospital in Northeast Ohio.
STP Implementation History
The Summer Treatment Program has been offered throughout the United States
including: Florida State University (1980-1986), the University of Pittsburgh Medical
Center (1987-1996), and the State University of New York (SUNY) at Buffalo (1997 to
present), Canada and Japan. This intensive treatment program has also been offered as a
part of further comprehensive treatment packages such as the National Institute of Mental
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Health Multimodal Treatment Study of Children with ADHD and the Early Risers
Program. To date, the program has been replicated at approximately 30 sites varying
from mental health agencies, University settings and national hospitals. Adolescent
programs of the STP have also been offered throughout the United States as well.
Numerous studies of child behavior and treatment responses have been conducted within
the context of the STP. Program efficacy has been evaluated in several studies and
reviewed by the Substance Abuse and Mental Health Service Administration’s
(SAMHSA) National Registry of Evidence-based Programs and Practices (NREPP). The
NREPP has independently assessed and rated the STP as high in quality of research and
readiness for dissemination (http://www.nrepp.samhsa.gov/ViewIntervention.aspx?id=8).
Data Collection
Prior to enrollment and acceptance into the program, parents signed informed
treatment consent forms which included information about current and future research
relating to the program. The behavioral clinic granted permission to analyze the archived
data and the documentation for use of the data can be found in Appendix (A). Likewise,
Cleveland State University’s (CSU) Institutional Review Board (IRB) approval was also
obtained (included in Appendix B).
Outcome data from the Summer Treatment Program was retrieved from the
previously created data set located within the behavioral clinic, which included all
weekly point totals obtained by every participant throughout the Summer Treatment
Program. Additional Summer Treatment Program records, weekly point totals,
individual treatment summaries and materials were reviewed. Information related to
ADHD diagnosis, comorbidity type, demographic and medication information, were
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collected and analyzed from the Summer Treatment Program to answer the four research
questions.
Ensuring Confidentiality
Steps were taken during the review of archived data to ensure confidentiality.
Previously collected Summer Treatment Program records, weekly point totals, individual
treatment summaries and materials were reviewed for the purposes of this dissertation
within the behavioral clinic. All dissertation study information related to ADHD
diagnosis, comorbidity type, demographic and medication information were stripped of
identifiers and re-coded. All children’s names were eliminated from the data set and
given a CSU ID code and numerical values were assigned to the following variables (STP
year, CSU ID, Program Year, Week/Time, Age, Group, Race, Gender, Primary
Diagnosis, Comorbidity, Comorbidity Type1, Comorbidity Type2, Comorbidity Type3 ,
Comorbidity Type4, STP Medication, Total weekly Pts).
Sample
During the summers from 1999 - 2012, participants enrolled in the Summer
Treatment Program (Summer Treatment Program, Pelham, Greiner et al., 2010) met
between June through July at various site locations including the campus of a small,
liberal arts colleges in Northeast Ohio (7 summers), local suburban elementary schools
(4 summers), and a Jewish Community Center (3 summers). Approximately 516 children
participated in the Summer Treatment Program (STP) sponsored through an ADHD
specialty clinic of a large, metropolitan children’s hospital in Northeast Ohio. Although
children may have participated in the program more than one year, for the purpose of this
dissertation, only first year participants were included. Children who had more than one
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exposure generally had a greater advantage and understanding of the nature and
expectations of the program and would presumably bias the sample.
The number of participants included in this dissertation research was reduced for
the following reasons: 140 subjects were removed because they were not first year
participants, 21 subjects were removed due to age exclusions (1 was 5 years old, 20 had
no age listed), 10 subjects were removed by primary diagnosis (3 Pervasive
Developmental Disorder, 1 cyclothymia, 1 Oppositional Defiant Disorder, 1 Mood
Disorder, 2 No diagnosis, and 2 were missing primary diagnosis. Also, due to small
comorbid confirmed diagnoses, children with Comorbid adjustment disorder (1),
enuresis/encopresis (4), subsyndromal yet clinically significant (8), and other (13)
comorbidities were excluded from the sample. An encouraging aspect of these data was
that the overall proportion of missing variables was low.
A final total of 345 subjects were selected for inclusion in this analysis. Subjects
had a median age of 8.53 years; were mostly male (77.1 %); predominantly Caucasian
(70.7 %), and diagnosed ADHD combined and hyperactive/impulsive type (93.6). Most
participants had at least one comorbid mental health diagnosis (52.8%), and had taken
some type of psychotropic medication (82.7%) while in the program.
The children participating in the summer treatment program were grouped by
their age, each treatment group consisting of 10 to 14 children, based on each child’s
birthday. Although the program also included an adolescent treatment groups, this
dissertation focused specifically on ages 6 to 12 year olds. The children’s names were
not included in this research; the data for this research was information that was collected
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as standard procedure for participation in the Summer Treatment Program. For this
dissertation, children’s data only included the first year participation in the program.
Recruitment, Screening and Application processes for the STP
Local education agency’s school personnel, mental health agencies, primary care
physicians, and social work professionals, as well as individual parents referred children
for enrollment into the Summer Treatment Program. Recruitment efforts were conducted
by local media advertising, such as brochures, informational workshops, and web
postings. Parent and Teacher rating scales/assessments, medical-social forms, birth,
family, and demographic questionnaires were included in application packets and sent via
US Mail to interested parents.
Behavioral and emotional rating scales collected from both parents and teachers
during the application and screening processes included the Achenbach Child Behavior
Checklist (Achenbach, 1999) and the Teacher Report Form (Achenbach, 1991), the
DuPaul ADHD Rating Scale-IV (DuPaul, Power, McGoey, Ikeda, & Anastopoulos,
1998), the Connors (1990, 2002) Abbreviated Symptom Questionnaire (ASQ) and the
Clinical Global Impressions Scale (Guy, 1976). These measures were used to assist with
the confirmation of ADHD diagnosis and acceptance into the summer treatment program.
Additionally, parents could supply copies of their child’s: Individual Education Plans,
mental health/psychological diagnostic assessments, and/or evaluations to assist in the
enrollment process. Parent and teacher scales/ratings were scored and evaluated to
confirm primary diagnosis of ADHD and inclusion into the program by the Clinical
director. If necessary, semi structured interviews with parent and child were necessary for
inclusion into the program in order to assist with diagnosis confirmation. These
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assessments and materials were all collected prior to the children’s participation in the
summer treatment program, for the program’s purposes, and were not collected for the
purposes of this research. The archived records, including weekly point totals, were the
data source to answer this study’s research questions and for the data analyses.
STP Inclusion and exclusion criteria
The records of the children meeting Diagnostic and Statistical Manual of Mental
Disorders-IV (American Psychiatric Association, 1994) and the Diagnostic and Statistical
Manual of Mental Disorders IV TR (American Psychiatric Association, 2000) symptom
criteria for attention-deficit/hyperactivity disorder (ADHD) are the records of interest for
this dissertation research and necessary for inclusion into the program. DSM-IV
attention-deficit/hyperactivity symptoms were rated by parents and teachers using the
ADHD Rating Scale (DuPaul et al., 1998). To enroll in the program, participants must
have been between the ages of 6 and 14 years of age and have met symptom criteria for
ADHD, either Combined Type, Predominantly Inattentive Type or Predominantly
Hyperactive-Impulsive Type. Comorbid mental health diagnoses and psychotropic
medication use were permitted. Although such diagnostic comorbidities were generally
allowable, the clinical director at each site may have excluded a child if it was determined
that the comorbid disorder was primary over the ADHD or that the severity of the
comorbid disorder would clearly disrupt the treatment (e.g., autism, schizophrenia,
bipolar disorder or conduct disorder with severe behavioral disruption). Fees for the
program were collected and based on the cost of providing intensive daily therapy and
interventions. Children who met the program's criteria were offered admission.
Demographics and descriptive information
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A description of the children who completed the summer program between 1999
and 2012 included a) the percentage of children diagnosed with ADHD by subtype,
namely ADHD-Combined Type, ADHD-Predominantly Inattentive Type, and ADHDPredominantly Hyperactive-Impulsive Type, b) percentage of children with comorbid
disorders by type, c) age, d) sex, and e) race are outlined in Table 1.
Table 1
Psychosocial and Demographic Variables: Descriptive Statistics (N=345)
Variables
Age
Number of comorbidities
Race/Ethnicity

M
8.53
0.71

SD
1.71
0.81

%

Caucasian
African American
Hispanic
Asian
More than one selected

70.7
18.6
2.3
2.0
6.1

Combined/hyperactive/impulsive
Inattentive

93.6
6.4

Yes
No

52.8
47.2

Yes
No

82.7
17.3

Male
Female

77.1
22.9

ADHD diagnosis type

Diagnosed comorbidity

Prescribed medication

Gender

Verification of ADHD Comorbidity
Application packets and materials, previously completed by parents and teachers
to rate ADHD symptoms, were required by the program in order for the clinical director
to confirm diagnoses of ADHD along with any possible comorbidities. All application
packets were reviewed by the clinical director prior to offering acceptance into the
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Summer Treatment Program. The Achenbach Child Behavior Checklist (CBCL;
Achenbach, 1999) and the Teacher Report Form (TRF; Achenbach, 1991), the DuPaul
ADHD Rating Scale-IV (ARS-IV; DuPaul, Power, Anastopoulos et al., 1998), the
Connors (1990, 2002) Abbreviated Symptom Questionnaire (ASQ) and the Clinical
Global Impressions Scale (CGI; Guy, 1976), were key in the confirmation of ADHD
diagnoses and comorbidities. Primary Diagnosis with comorbidity type was then
transcribed onto a separate form, “ADHD application review and acceptance form” (see
appendix C) which was located in every child’s file and co-signed by the Clinical
Director. The “ADHD application review and acceptance form” served the purpose of
confirming that the child met criteria for primary diagnosis of ADHD, listed all
comorbidities, and verified that the child was accepted into the program. For the purpose
of the dissertation, the “ADHD application review and acceptance form” was reviewed
for ADHD diagnosis and comorbidity type and collected for this research.
Definition of Comorbid Subgroups
Additional diagnostic information was collected and evaluated as part of the STP
application process, including symptoms of oppositional-defiant disorder (ODD), bipolar
disorder (BP), conduct disorder (CD), pervasive developmental disorder (PDD), anxiety
(ANX), obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD) and
depression (DEP).
For the purposes of this dissertation research, children were also identified as having
ADHD alone or as having ADHD with an additional diagnoses (CO1) noting those with
two diagnoses [CO2], or three [CO3] as outlined in Table 2.
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Table 2
Descriptive Statistics of Comorbidity Type (N=345)
Type

N

%

Anxiety disorders (OCD, PTSD)

44

13.0

Mood disorders (depression, bipolar)

37

10.7

Opposition defiant disorder

45

13.0

Pervasive developmental disorders (Asperger’s, autism spectrum

26

7.5

Tic-Tourette’s

22

6.3

Learning disorder

42

12.5

No Comorbidity

163

47.2

One Comorbidity

33

9.6

Three Comorbidities

15

4.3

Procedures
The Summer Treatment Program is a 7-week, intensive summer behavioral
intervention program designed for children diagnosed with ADHD, aged 6 to 12 years
old, as well as an adolescent group for ages 12 to 14. Children aged 6 to 12 years of age
attended from 8:30 AM to 5:30 PM, Monday through Friday, and adolescents attended
from 8:00 AM to 5:50 PM weekdays as well. For the purpose of the dissertation, archival
data from the adolescent component was not studied.
Quite similar to a day treatment program, the STP tailors individualized treatment
goals specific to the needs of each child. Generally, 10 -14 children comprised a
treatment group with 5 to 6 clinical staff members present. Groups were facilitated by a
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graduate level lead counselor and 4 or 5 undergraduate level group counselors. The team
of group counselors monitored children closely throughout the day, implementing the
program and recording behaviors. Prior to working with children, all staff received two
weeks of intensive training covering the entire program manual. All staff members and
counselors hired for the program were required to pass an operational definitions exam
covering all aspects of the Summer Treatment Program (point system behaviors, lists of
rules for all activities, hierarchical system for classification of behaviors).
Throughout the day, children engaged in social skills training, recreational
activities, and skill drills for the following sports: basketball, softball and soccer, as well
as swimming. Children also participated in academic learning centers, instructed by
elementary school teachers, to strengthen their ability to follow through with instructions,
attend to and complete tasks, and comply with adults' requests in the classroom (Caserta,
2008). Academic learning centers were designed similarly to elementary school
classroom settings and children participated in computer and art instruction by specialty
teaching staff. Children and counselors remained in their assigned group throughout the
summer to build relationships and consistency. The children spent 3 hours daily in
learning centers (LC), including an Academic LC, a Computer LC, and an Art LC.
Again, these classrooms were supervised by developmental specialists (typically special
education teachers), and developmental aides (undergraduate students). These staff
members implemented behavior modification programs designed to treat children's
problems in a classroom context. Children spent the remainder of each day engaging in
recreationally based group activities, while under the supervision of the counselors.
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Weekly parent training classes and medication assessments were also vital parts
of the Summer Treatment Program. One evening a week, each child’s parent/s was
invited to participate in training sessions held by the clinical director to learn skills and
strategies to improve the parent-child relationship and behavior management skills for
home. Although not required, some parents and children participated in medication trials
designed to assist the family in evaluating the optimal medication dosage while
participating in the STP.
Dependent Variable: Point System and Token Economy
The point system, or token economy, is a major component of the STP
intervention, and children earned or lost points contingent upon their behaviors. Children
earned points and exchanged them for a variety of rewards, including home and program
privileges, field trips, and special honors. The point system served the following two
primary functions in the STP: 1) one of the main procedures used to increase the
frequency of appropriate behaviors and to decrease the frequency of undesirable
behaviors exhibited by the children in treatment and 2) the primary data system for the
STP. Accurate recording of positive and negative behaviors provided the clinical staff
members with the necessary information for developing and monitoring a child’s
treatment. In addition to helping determine the nature of the children's behavior
problems, the data was used to evaluate response to treatment, as significant changes in
the frequencies of behaviors may reflect positive responses to behavioral treatment.
This token economy varied slightly as a function of the activities in which the
children and adolescents participated. Namely, during the four 1-hour, recreational
activities, children continuously earned points for exhibiting appropriate behaviors and
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lost points for exhibiting inappropriate behaviors; whereas, during the three classroom
activities, the behavioral system was less complex and involved a reward and a response
cost system in which children began each learning center with 100 points and lost 10
points for each rule violation.
Throughout the day, staff members recorded the frequency of both positive,
prosocial behaviors and negative, disruptive behaviors. There were nine prosocial
behaviors that were socially desirable and 16 negative behaviors which were undesirable.
The point system behaviors were operationally defined and mandated whether points
were awarded or taken away for a specific action or verbalization. The positive category
behaviors included: Following Activity Rules, Good Sportsmanship, Behavior Bonus,
Attention, Compliance, Helping a Peer, Sharing with A Peer, Contributing to Group
Discussion, and Ignoring a negative stimulus. The negative category behaviors included:
Violating Activity Rules, Poor Sportsmanship, Intentional Aggression toward a peer or
staff member, Unintentional Aggression toward a peer or staff member, Intentional
Destruction of Property, Unintentional Destruction of Property, Noncompliance,
Repeated Noncompliance, Stealing, Leaving the Activity Area without permission,
Lying, Verbal Abuse to Staff, Name Calling/Teasing, Cursing/Swearing, Interruption,
and Complaining/Whining.
The daily frequencies of behaviors have been demonstrated to hold validity in
assessing children’s responses to both behavioral and pharmacological treatments
(Pelham & Hoza, 1996). Point system behaviors throughout the STP were, therefore,
used as dependent measures of children’s responses to treatment. Behavioral data for
every child was entered into a computer database at the end of the treatment day by two

74

group counselors from each child’s group which allowed for evaluation of the frequency
with which children exhibited both prosocial and disruptive behaviors. Means for every
point system behavior were automatically calculated on a daily basis, which allowed for
not only the evaluation of specific behavioral changes, but also the speed with which
children changed such behaviors over time. For this dissertation, the amount of points
earned by each child was calculated to show treatment outcomes compared by age,
gender, and comorbidity type. The more points a child earned therefore reflected more
appropriate and positive behavior. The weekly point totals for participants from 1999 to
2012 ranged from -40910 to 21340 (M=6301, SD=7820). Weekly point total scores were
considered the dependent variable for this dissertation. A summary of weekly point totals
is outlined in Table 3.
Table 3

Summary of Total Weekly Points Earned During Weeks 2 – 6 (N=345)
Missing
Total weekly points

35

N

Mean

1689

6301

SD
7820

Minimum
-40910

Median

Maximum

7585

21340

Treatment Integrity and Fidelity
The summer treatment program includes treatment integrity and fidelity checks
and quizzes. Treatment integrity and fidelity checks were conducted weekly by the
Clinical Director to ensure that the intervention was implemented as intended. Feedback
was given to lead counselors, group counselors and teaching staff during the program, as
well, to prevent serious errors which can occur when interpreting treatment responses.
Treatment integrity and fidelity checks are an important part of the manualized program
and designed to maximize Pearson correlations between the observations made by staff
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members and those made by trained independent observers. Previous studies have
demonstrated Pearson correlations above .8 (Chronis et al., 2004).
In addition, children’s daily point totals were entered in the Summer Treatment
Program Data base by two staff members to ensure accurate data entry and consistent
data reliability of the summer treatment program. Treatment integrity and fidelity was
critical to both the clinical treatment being offered at the time of the program and for
further investigation of research projects in the future.
Daily Report Card
Although the STP provides a standardized manual for implementation of the
group treatment, treatment is individualized for each child through the development of a
Daily Report Card (DRC). Children’s behaviors were monitored during the first week of
the program in order to identify target behaviors that were creating the most significant
impairment. After identifying these individualized, target behaviors, staff members
calculated the child’s daily average instances of each behavior and set a goal for the child
to reach at the start of the second week of the program. Target goals would be adjusted
based on their lack of success, whereby the goals may have actually been increased (for
negative behaviors) or decreased (for positive behaviors) in order to continuously allow
the child to succeed with a target goal. Children that met 75 percent of their daily report
card during the week could earn a weekly field trip reward on Fridays. The weekly
success of the daily report card is an important component of the summer treatment
program; however due to the variability of each child’s target goals, the success was not
utilized as an indicator of the rate of change for this dissertation.

76

Treatment Outcomes
For this dissertation, treatment outcomes were measured by the rate of change for
age groups, gender, and comorbidities. The dependent measures included an analysis of
the point system behaviors recorded during the program from baseline to end of
treatment. For the purposes of this dissertation research, treatment outcomes were
assessed via the point system behaviors from weeks 2 through 6. The first week of the
program is generally considered the “honeymoon” and the last week of the program
considered the “termination week.” Children’s weekly scores during weeks 1 and 7 were
not true indications of their individual responses to treatment. Similarly, the program
completed individual treatment reports detailing each child’s individual daily report card
treatment outcomes based on Weeks 2 through 6. Therefore, similar to the program’s
individual treatment summary reports, this dissertation focused on treatment outcomes of
the 14 years of data from program weeks 2 through 6, as well.
Analyses and Statistics
For the purposes of this dissertation research, linear mixed effects regression
analysis was selected. Mixed-effects regression models are advantageous relative to
standard repeated-measures analysis of variance because of their ability to accommodate
missing data (not all archival data was captured due to some incomplete values (e.g. some
children missed a week of data for vacation purposes and subjects not finishing program)
to explicitly model relationships between repeated measures (rather than assuming
sphericity), and to directly model the effects of time (Manos et al.; 2012).
Numerical measures were summarized by median and interquartile range.
Categorical variables were summarized by frequency and percentage. Univariable
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comparisons by comorbidity status were performed, utilizing Wilcoxon's rank sum test,
and chi square tests. The test use was denoted in the output, see Table 4.
Table 4
Comparison of Subject Descriptors by Comorbidity Status
No
Factor
Age

a

Total

N

Statistics

N

Statistics

p-value

345

163

8 [7, 10]

182

8 [7, 10]

0.055W

b

345

Caucasian

244

112

45.9

132

54.1

Other

101

51

50.5

50

49.5

Race

Gender

b

0.51C

0.42C

345

Female

79

41

51.9

38

48.1

Male

266

122

45.86

144

54.14

Age Group

a

Yes

b

0.13C

345

1

125

69

55.2

56

44.8

2

96

39

40.62

57

59.38

3

108

49

45.37

59

54.63

4

16

6

37.5

10

62.5

Median [P25, P75]; b Percentage

C: Pearson's Chi-squared test with Yates' continuity correction
W: Wilcoxon rank sum test with continuity correction
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Table 4 (continued)
Comparison of Subject Descriptors by Comorbidity Status

Factor
Summer treatment program year

a

b

No
Yes
Total N Statistics N
Statistics p-value
345
0.54C

1999

38

17 44.74

21

55.26

2000

20

10 50

10

50

2001

28

16 57.14

12

42.86

2002

21

7

33.33

14

66.67

2003

21

8

38.1

13

61.9

2004

27

11 40.74

16

59.26

2005

22

6

27.27

16

72.73

2006

22

10 45.45

12

54.55

2007

29

13 44.83

16

55.17

2008

25

14 56

11

44

2009

23

13 56.52

10

43.48

2010

27

15 55.56

12

44.44

2011

21

10 47.62

11

52.38

2012

21

13 61.9

8

38.1

Median [P25, P75]; b Percentage

C: Pearson's Chi-squared test with Yates' continuity correction
W: Wilcoxon rank sum test with continuity correction
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Total weekly points were modeled using linear mixed effects methods with
comorbidity status, age, gender, and race as independent variables. Whereas the data
were relatively balanced (the same number of observations per subject), 95% confidence
intervals and p-values were calculated from normal standard errors. Subject ID was
entered as the random effect and evaluated by visual inspection of plots and a likelihood
ratio test. Additional models for weekly points were developed to evaluate the
relationship of specific comorbidities on weekly points. Treatment outcomes are reported
based on results from weeks 2 through 6 of the Summer Treatment Program. A linear
mixed effects methods analysis was conducted with the dependent measures for the age
group, comorbidity, and gender comparisons to test all four research questions (see
Appendix D). The research questions are as follows:
1.

Do children diagnosed with ADHD alone, who attend an intensive
summer treatment program, differ in treatment outcomes from those
children diagnosed with ADHD comorbidity?

2.

Do males diagnosed with ADHD comorbidity, who attend an intensive
summer treatment program, differ in treatment outcomes from females
with ADHD Comorbidity?

3.

Are there age group differences in treatment outcomes with children
diagnosed with ADHD comorbidity who attend an intensive summer
treatment program?

4.

Do children with different comorbid diagnoses and ADHD, who attend an
intensive summer treatment program, differ in treatment outcomes?
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Conclusion
Over a fourteen year period, from 1999 -2012, the collection of data from the
Summer Treatment Program (STP) offered through an ADHD specialty clinic of a large,
metropolitan children’s hospital in Northeast Ohio, offered this researcher an opportunity
to analyze the aforementioned research questions. This chapter provided specific
information about the STP participants, the program, the procedures, instruments, and the
data analyses. Chapter Four provides the results of the linear mixed effects methods
analysis performed on all four research questions.
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CHAPTER IV
RESULTS
This chapter is organized around the sequence of the research questions. Each
question is stated and followed by the results of the analyses. The tables of the output are
given to assist with explanation of the findings.
Research Question 1
Do children diagnosed with ADHD alone, who attend an intensive
summer treatment program, differ in treatment outcomes from those
children diagnosed with ADHD comorbidity?
No, the children diagnosed with ADHD alone did not differ in treatment
outcomes from those with ADHD Comorbidity. Week two mean predicted score of the
comorbidity group was lower than in the no comorbidity group (5673.95 compared to
6057.71, respectively). This pattern was also true for week 6, although the difference
increased very slightly (7808.50 compared to 8192.27, in the comorbidity and no
comorbidity groups, respectively), as outlined in Table 5.
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Table 5:
Predicted Weekly Scores in No Comorbidity vs. Comorbidity by Week (N=345)
Program Week

ADHD Alone

ADHD with Comorbidity

2

6057.71

5673.93

3

6821.24

6437.47

4

7439.75

7055.98

5

7754.64

7370.88

6

8192.27

7808.50

In both groups, predicted weekly scores showed consistent improvement from
week two through week six. While the children with at least one comorbid diagnosis
scored consistently lower than their ADHD alone counterparts, they appeared to have a
similar relative benefit to their baseline scores. Over the course of the program, it was
estimated that children with comorbidities would score an average of -375.24 points
lower than children with ADHD alone. This difference was not statistically significant
(Beta = -375.24; T = -0.60; df = 331; p = 0.55), see Table 6.
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Table 6:
Linear Mixed Effects Model Summary for Total Weekly Points and Comorbidity
Factor

Level

(Intercept)

Beta

95% Confidence Interval

T

P-value (T)

319.3

(-3380.19, 4018.81)

0.17

0.87

-375.2

(-1598.07, 847.59)

-0.60

0.55

Comorbidity

Yes vs. No

Week/time

3 vs. 2

771.3

(183.11, 1359.44)

2.57

0.01

4 vs. 2

1385.5

(804.38, 1966.61)

4.68

< 0.001

5 vs. 2

1698.6

(1115.54, 2281.62)

5.71

< 0.001

6 vs. 2

2140.7

(1555.3, 2726.15)

7.17

< 0.001

781.5

(419.4, 1143.61)

4.23

< 0.001

-301.7

(-1666.69, 1063.36)

-0.43

0.66

-1382.8

(-2866.02, 100.38)

-1.83

0.068

-718.9

(-2351.16, 913.3)

-0.86

0.39

Age
Race

Other vs. Caucasian

Gender

Male vs. Female

Medications
Yes vs. No
during STP

Additionally, an interaction between comorbidity status and week was
investigated. The presence of such an interaction would indicate that change in total
weekly scores develop at different rates in the comorbidity and ADHD alone groups
across time (e.g., non parallel slopes). Results reported in the ANOVA table showed no
overall effect for this interaction, suggesting that the interaction may be left out of the
model (F = 1.06; num. df = 4, den. df = 331; p = 0.38). See Table 7.
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Table 7
Analysis of Variance Table: Comorbidity and Week Interaction
Df

Sum Sq

Comorbidity

1

6.13e+05

Week.Time_factor

4

Age

Mean Sq

F value

P

6.13e+05

0.04

0.839

9.29e+08

2.32e+08

15.77

0.000

1

2.95e+08

2.95e+08

20.03

0.000

Race2

1

1.32e+05

1.32e+05

0.01

0.925

Gender

1

4.81e+07

4.81e+07

3.27

0.072

STP.Med

1

1.10e+07

1.10e+07

0.74

0.389

Comorbidity:Week.Time_factor

4

6.22e+07

1.55e+07

1.06

0.378

Comorbidity:Age

1

1.98e+07

1.98e+07

1.34

0.247

Week.Time_factor:Age

4

1.70e+08

4.25e+07

2.89

0.023

Comorbidity:Gender

1

1.02e+07

1.02e+07

0.69

0.406

Comorbidity:Week.Time_factor:Age 4

6.80e+07

1.70e+07

1.15

0.331

Research Question 2
Do males diagnosed with ADHD comorbidity, who attend an intensive
summer treatment program, differ in treatment outcomes from females
with ADHD comorbidity?
Yes, the males diagnosed with ADHD comorbidity did differ in treatment
outcomes from females. Week two mean predicted score for females was higher than for
males (8126.83 vs. 5819.17, respectively). This pattern was also true for week 6
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(10672.22 compared to 8364.55, in the females and males, respectively), as outlined in
Table 8.
Table 8
Predicted Weekly Scores for Female Comorbidity vs. Male Comorbidity by Week (N=
182)
Program Week

Female Comorbidity

Male Comorbidity

2

8126.83

5819.17

3

9321.69

7014.03

4

9645.69

7338.03

5

10284.03

7976.37

6

10672.22

8364.55

In both genders, predicted weekly scores showed consistent improvement from
week two through week six. While males scored consistently lower than females, they
appear to have a similar relative benefit to their baseline scores. Over the course of the
program, it is estimated that males will score an average of -2307.66 lower than females.
This difference is statistically significant (Beta = -2307.66; T =-2.08; df = 170; p =
0.038), see Table 9.
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Table 9
Linear Mixed Effects Model Summary for Total Weekly Points and Gender Comorbidity
Factor
(Intercept)
Week/time

Level

Beta 95% Confidence Interval P-value (T)
1592
(-3744.06, 6928.29)
0.56
3 vs. 2
1195
(411.77, 1977.96)
0.003
4 vs. 2
1519
(745.36, 2292.38)
< 0.001
5 vs. 2
2157
(1380.24, 2934.17)
< 0.001
6 vs. 2
2545
(1771.88, 3318.9)
< 0.001
Age
1495
(-24.89, 3013.93)
0.054
Race
Other vs. Caucasian -1063
(-3044.29, 918.9)
0.29
Gender
Male vs. Female
-2308
(-4483.72, -131.6)
0.038
Medications during STP Yes vs. No
1033
(-1310.99, 3376.48)
0.39

Research Question 3
Are there age group differences in treatment outcomes with children
diagnosed with ADHD comorbidity, who attend an intensive summer
treatment program?
No, there were not age group differences in treatment outcomes with children
diagnosed with ADHD comorbidity. Week two mean predicted score for six year olds
was lower than 12 year olds (4075.56 compared to 7064.60, respectively). This pattern
was also true for week 6 (6620.95 compared to 9609.99, in the 6 year olds and 12 year
olds, respectively), see Table 10.
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Table 10
Predicted Weekly Scores for Age of Participants by Week (N=182)
Week

Age 6

Age 7

Age 8

2

4075.56

4573.73

3

5270.42

4

Age 9

Age 10

Age 11

Age 12

5071.90 5570.08

6068.25

6566.43

7064.60

5768.60

6266.77 6764.94

7263.12

7761.29

8259.46

5594.43

6092.60

6590.77 7088.95

7587.12

8085.29

8583.47

5

6232.76

6730.94

7229.11 7727.29

8225.46

8723.63

9221.81

6

6620.95

7119.12

7617.29 8115.47

8613.64

9111.81

9609.99

In all ages, predicted weekly scores showed consistent improvement from week
two through week six. While younger participants scored consistently lower than older
participants, they appeared to have a similar relative benefit to their baseline scores. Over
the course of the program, it was estimated that each year of increased age associated
with an increase of 1494.52 points. The effect of age on weekly score was cumulative.
Although this difference was not statistically significant (Beta = 1494.52; T = 1.93; df =
170; p = 0.054; as outlined in Table 11), the general trend shows that a seven year old
would be expected to score 1494.52 more points than a six year old, and that an eight
year old would score 2989.04 more points than the six year old, as the effect on weekly
score is cumulative.
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Table 11
Linear Mixed Effects Model Summary for Total Weekly Points and Age
Factor
(Intercept)
Week/time

Level

Beta 95% Confidence Interval P-value (T)
1592
(-3744.06, 6928.29)
0.56
3 vs. 2
1195
(411.77, 1977.96)
0.003
4 vs. 2
1519
(745.36, 2292.38)
< 0.001
5 vs. 2
2157
(1380.24, 2934.17)
< 0.001
6 vs. 2
2545
(1771.88, 3318.9)
< 0.001
Age
1495
(-24.89, 3013.93)
0.054
Race
Other vs. Caucasian -1063
(-3044.29, 918.9)
0.29
Gender
Male vs. Female
-2308
(-4483.72, -131.6)
0.038
Medications during STP Yes vs. No
1033
(-1310.99, 3376.48)
0.39

Research Question 4
Do children with different comorbid diagnoses and ADHD, who attend an
intensive summer treatment program, differ in treatment outcomes?
Only one comorbid diagnosis was associated with statistically significant
differences in weekly scores. Specifically, children with ADHD and ODD earned
significantly fewer points than children with ADHD only. Children with this comorbid
diagnosis earned 2048.7 fewer points than those with no comorbidities. This difference in
scores ranged from -4015.76 to -81.64 points. These results did demonstrate statistical
significance (Beta = -2048.7; T = -2.0438; df = 198; p = 0.041). All other comorbid
diagnoses examined in this analysis were not associated with differences in treatment
outcomes when compared to children with no comorbidities. Interestingly, among all
children with at least one comorbidity, children with learning disorders had the highest
mean weekly scores (7909.00), while children diagnosed with ODD scored the lowest
(3973.00), see Table 12.
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Table 12
Mean Summary of Weekly Scores by Number of Comorbidities and Type
Number of Mean Weekly

Mean Second

Mean Sixth

Subjects

Score

Week Score

Week Score

No comorbidities

163

6385

5459

7272

One comorbidity

131

6202

4968

7229

Two comorbidities

33

6508

4642

7946

Three comorbidities

15

5821

4080

6390

Anxiety D/O, OCD, PTSD

44

6474

5511

7496

Mood

37

6449

4128

7802

ODD

45

3973

3446

4438

spectrum

26

4780

2488

5763

Tic-Tourettes

22

6661

4325

8068

Learning disorder

42

7909

6261

9407

PDD, aspergers, autism

Children with comorbid anxiety scored 734.27 lower than children with ADHD
alone, though this difference may range from -2613.69 to 1145.16 points. The difference
associated with an anxiety comorbidity was not statistically significant (Beta = -734.27; T
= -0.7667; df = 198; p = 0.44). Children with mood comorbidities scored 394.44 lower
than subjects with ADHD alone, though this difference may range from -2366.29 to
1577.4 points. The difference associated with a mood comorbidity was not statistically
significant (Beta = -394.44; T = -0.3926; df = 190; p = 0.69). Children with any one
comorbid diagnoses scored 358.02 lower than children with ADHD alone; children with
two comorbid diagnoses scored 189.46 higher and those with three comorbidities scored
843.59 lower than those with no comorbidities. None of these comparisons, however,
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demonstrated statistical significance (Beta1 = -358.02; T1 = -0.5346; df1 = 335; p1 =
0.59: Beta2 = -189.46; T2 = -0.1726; df2 = 335; p2 = 0.86:Beta3 = -843.59; T3 = 0.5461; df3 = 335; p3 = 0.59:) It would appear that, although the pathologies and
symptomatic behaviors of the various comorbidities differed, the treatment program
showed similar results over all of the diagnoses and may be of benefit to children with
any of these comorbid diagnoses, see Table 13. For complete model summaries of linear
mixed effects for each comorbidity type and total weekly scores, see Appendix E.
Table 13
Linear Mixed Effects Model Summary for Total Weekly Points and Comorbidity
P-value
Factor

Level

Beta

SE

Lower

Upper

T
(T)

Anxiety D/O, OCD,
PTSD

Yes vs. No

-734.3

957.8 -2613.7 1145.16 -0.7667

0.44

Mood

Yes vs. No

-394.4

1004.8 -2366.3 1577.40 -0.3926

0.69

ODD

Yes vs. No

-2048.7

1002.4 -4015.8

-2.0438

0.041

autism spectrum

Yes vs. No

-1145.0

1212.6 -3524.8 1234.86 -0.9442

0.35

Tic-Tourettes

Yes vs. No

532.2

1274.7 -1969.5 3033.85

0.4175

0.68

Learning disorder

Yes vs. No

884.0

0.9594

0.34

1 vs. 0

-358.0

955.53 -0.5346

0.59

2 vs. 0

-189.5

1098.0 -2343.0 1964.08 -0.1726

0.86

3 vs. 0

-843.6

1544.8 -3873.6 2186.44 -0.5461

0.59

-81.64

PDD, aspergers,

921.4

-924.1 2692.02

Number of
Comorbidities

669.7 -1671.6
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Summary
This chapter presented the analyses for each of the four research questions.
Overall findings suggest that the total weekly points did not differ by comorbidity status,
in that subjects with comorbid diagnoses demonstrated the same improvement in scores
as subjects without additional comorbidities. Males had significantly lower total scores
than females; however, while older subjects scored consistently higher than younger
subjects, these differences were not significant. Children with a dual diagnosis of ADHD
and ODD were the only children with comorbidities who evidenced significantly lower
total points compared to children with no comorbidities. Furthermore, weekly scores
were shown to improve steadily from week two through week six.
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CHAPTER V
DISCUSSION
This chapter presents a discussion of the dissertation results. After the results for
each research question are presented along with a general discussion, the implications
that follow from the findings are explicated. Then, a discussion of the possible limitations
of this study is outlined. Finally, this chapter ends with recommendations for future
research and a general conclusion statement.
Discussion of Results per Research Question
Research question one. Children diagnosed with ADHD alone, who attended an
intensive summer treatment program, did not differ in treatment outcomes from those
children diagnosed with ADHD and at least one comorbid mental health diagnosis. When
comparing average total points earned during each week of the STP, while children with
ADHD only began and ended the program earning more points than children with ADHD
plus comorbidity, these differences were not statistically significant. In both groups,
average weekly point totals improved consistently from week two through week six. This
demonstrates the efficacy of the STP for all children diagnosed with ADHD regardless of
the presence of a dual diagnosis.
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One interesting finding involved the lack of an interaction effect between the
presence of comorbidity and week of the program. Children who do not demonstrate
positive responses to the basic behavioral program are typically placed on an
Individualized Treatment Plan (ITP), and children with comorbidities are usually those
requiring individualized treatment. Given that an ITP is usually implemented only after
sufficiently illustrating that the regular elements of the STP are not resulting in positive
behavioral changes, an ITP is typically not initiated until the third or fourth week of the
program. As such, it may have been predicted that children with comorbidities would
take longer into the 7-week program to show positive responses. The lack of an
interaction effect, therefore, may provide evidence that the process of implementing ITPs
levels the proverbial playing field for children with ADHD and significant comorbidities
Research question two. Among males and females diagnosed with ADHD and a
comorbid mental health issue, males were out performed by females and therefore
differed in their treatment outcomes. Unlike the results of the first research question,
when comparing average total points earned during each week of the STP, the differences
in points earned were statistically significant, and females earned more points than their
male counterparts. While females with ADHD comorbidity began and ended the program
earning more points than males with ADHD comorbidity, the average weekly point totals
of both genders improved consistently from week two to week six. The finding that
females consistently earned more points than males is interesting when considering the
prevalence rates of ADHD generally and which subtype of ADHD is most common
among girls versus boys.
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While the male-female ratio of the sample (3.5:1) was comparable to the ratios
estimated in the DSM-IV-TR (2:1 to 9:1; American Psychiatric Association, 2000), one
variable not included in these analyses involved ADHD diagnostic subtype by gender.
This may be relevant in that females are more commonly diagnosed with ADHD
Predominantly Inattentive Subtype than males, who are most often diagnosed with
ADHD Combined Subtype or ADHD Predominantly Hyperactive/Impulsive Subtype
(American Psychiatric Association, 2000). In this sample, of the 79 female subjects, 10%
(n=8) had a primary diagnosis of ADHD Predominantly Inattentive Subtype, whereas 14
of the 266 male subjects (5%) had a primary diagnosis of ADHD Predominantly
Inattentive Subtype. As such, this difference may have accounted for the finding that
males earned fewer points overall than females. Here, it would be expected that children
with primarily inattentive symptoms, as compared to those with primarily hyperactive
and impulsive symptoms, would exhibit fewer rule violations overall and, therefore,
would lose fewer points during the treatment program.
Research question three. While there were age group differences in treatment
outcomes with children diagnosed with ADHD comorbidity, the differences were not
statistically significant. Results from this dissertation illustrated that older children earned
more points on average than younger children. This finding is consistent with previous
research (Manos, et al. 2012) that suggests older children enrolled in the STP exhibit
more positive and less negative behaviors than younger children. The normative behavior
data collected by Pelham et al. (1998) demonstrated that even children without a
diagnosis of ADHD show a similar developmental trend, in that older children (i.e., ages
10-12) exhibit fewer negative behaviors (e.g., violating activity rules, interruption, poor

95

sportsmanship) and more positive behaviors (e.g., helping, sharing, ignoring) than
younger children (i.e., ages 7-10). Therefore, given that children earn points for positive
behaviors and lose points for negative behaviors, it is not surprising that younger subjects
were found to earn significantly fewer total points on average as compared to older
subjects.
Research question four. With the exception of children dually diagnosed with
ADHD and ODD, children with other comorbid diagnoses and ADHD, who attended an
intensive summer treatment program, did not differ in treatment outcomes as measured
by total average points earned. Therefore, the overall findings suggested that total weekly
points neither differed by comorbidity types nor number of comorbidities. Similarly, the
number of diagnosed comorbidities did not significantly affect children’s earned total
average points. Furthermore, weekly scores were shown to improve steadily from week
two through week six, regardless of presence or number of comorbidities. Similar to the
findings of the first research question, regardless of the number of comorbidities,
children’s average weekly point totals improved consistently from week two through
week six, which again provides further support for the efficacy of the STP.
Interestingly, extant research has demonstrated that one of the most common
ADHD comorbidities is ODD (Efron & Schibberas, 2010). Given this finding, combined
with the fact that children with ODD exhibit significantly more clinical oppositionality
than children with ADHD only, it is not surprising that the participants in this study with
ADHD plus comorbid ODD earned the fewest amount of total points compared to
children with other ADHD comorbidities, which was statistically significant.
Additionally, it is also important to consider the influence of group interactions and group

96

composition as it relates to the findings. In this dissertation, children with ADHD and
ODD comprised the greatest number of subjects with ADHD comorbidity. Again, given
the finding that children dually diagnosed with ADHD and ODD scored significantly
fewer points, the findings are consistent with similar research (Macgowan & Wagner,
2005) which suggests groups with higher percentages of children with disruptive
behavior disorders (such as conduct disorder and ODD) display greater antisocial
behavior in groups.
Another interesting finding is that children diagnosed with ADHD plus LD
consistently earned more points than children diagnosed with ADHD plus any other
comorbidity. This supports previous research that found that girls diagnosed with ADHD
and LD have few behavioral problems relative to those with a diagnosis of ADHD only
(Marks et al., 2002). Furthermore, given the clinical difficulties involved in
differentiating symptoms associated with ADHD versus those associated with LD, this
finding may provide evidence that children with learning disabilities may be improperly
diagnosed with comorbid ADHD. Consider, for example, a child with a reading disorder
who avoids homework, has difficulty focusing on homework, and needs almost constant
redirection during academic tasks. Without the extensive psychological testing that is
required in order to confirm ADHD symptoms across multiple domains, this type of child
may incorrectly be labeled as ADHD Predominantly Inattentive Subtype.
Implications/Suggestions for Future Research
This research is important for several reasons. It suggests that clinicians
providing intensive behavioral treatments like the STP may include children with ADHD
only and those with ADHD and most comorbidities without fear that the latter group of
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children will not benefit. Future research, however, should explore other mediating
and/or moderating factors that may account for positive outcomes of children diagnosed
with ADHD and other comorbidities. For example, by comparing children in the STP
diagnosed with ADHD alone to children with multiple diagnoses or comorbidities, better
treatment matching may be gained and may also reduce some of the clinical uncertainty
that exists in the literature with regard to treatment options. Certainly, these potential
findings may lead to additional research and treatment studies, as well as provide support
for the clinical process of matching patients to treatment in the future. Also, children
diagnosed with ADHD, including those with comorbidity, show improvement when
enrolled in a comprehensive treatment program like the STP. Although in some cases the
findings were not statistically significant based on the key dependent variable (i.e., total
average points earned each week), the findings did reveal that clinically meaningful
changes were made by the children enrolled in the STP. If a child is able to increase his
or her average total points earned week to week, then it would be evidence of clinical
improvement. More importantly, these findings indicate that the comprehensive
interventions offered by the STP resulted in similar clinical outcomes regardless of
gender, comorbidity type, and comorbidity number.
The near significant difference found across age may have important clinical
implications for practitioners working with children diagnosed with ADHD via positive
behavioral programming, especially when considering a patient’s developmental and
chronological age. Developmentally, older children may be more likely to shape their
behaviors under the type of positive behavioral contingencies offered in the STP given
the greater importance that they place on social acceptance. Additionally, the amount of
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an individual’s social awareness has been demonstrated to be maturational in nature, and
this finding is present with or without a diagnosis of ADHD. In other words, as all
children develop, they become more socially aware and, therefore, are more likely to
adapt their behavior to fit the situation. This finding may be even more pronounced in
children diagnosed with ADHD, who often lag behind their similar-aged peers from a
social-developmental perspective. In the same manner, when planning for behavioral
interventions, practitioners may anticipate the need to manage more challenging and
disruptive behaviors from children diagnosed with ADHD plus ODD relative to their
ADHD only counterparts. Once again, findings indicated that children with ADHD plus
ODD earned fewer overall points, which suggests that they may present with more
negative behaviors and therefore require more clinical attention.
Future research may also focus on treatment outcomes for children who return for
multiple years to the STP, as compared to just one year. No such research has been
conducted to date. It may be hypothesized that children who return for additional years of
the summer treatment program would show significant differences in treatment outcomes
compared to those who attend only one time. Specifically, multiple exposures to the STP
may result in more improvement year to year. However, there may also be a plateau
effect expected, such that children who return for several consecutive years fail to make
additive gains year to year. Clinically, this would be invaluable information for
practitioners to share with parents, teachers, and providers who may be struggling with
the important decision of whether to reenroll their child, student, or patient for another
year or years. Possible variables to explore within this research question include baseline
severity of ADHD, parent sense of competence, treatment adherence (both parent and
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child), and family resources. All of these factors may influence not only a child’s need to
return for another round of treatment, but also a family’s ability to do so.
Finally, when considering the value of an intensive treatment program such as the
STP, future studies may explore not only the clinical implications for children with
comorbid ADHD, but may focus on the practical implications including the transfer of
treatment and generalizability of treatment gains to both the home and school settings for
parents and educators. As related to the home setting, future study may look at treatment
outcomes based on the level of parent involvement as possibly measured by the number
of parent training sessions and booster trainings attended by the parents of children with
comorbid ADHD. It may be hypothesized that children whose parents attended and fully
participated in the STP training and booster sessions would show significant differences
in treatment outcomes compared to those whose parent/s that did not. Home assessments
could also be developed to assess generalizability of STP behaviors to the home
environment.
Future study may also explore the relationship between children attending an
intensive behavior program and academic achievement. Possible variables to explore
within this future research question include: total STP points earned, school behavior
reports, school suspension/expulsion data, and academic grades. Ultimately this future
research may shed light onto the efficacy of an intensive behavior treatment program
when transferred to the school settings. For parents and teachers working with or who
have children with ADHD comorbidity, the questions and answers learned would be
valuable information.
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Limitations
Just as this chapter acknowledged implications, limitations do exist. For example, not
controlling for the program year, site location, and the use of psychotropic medication
and status in the analyses could be viewed as limitations. First, due to the fact that the
Summer Treatment Program was manualized and contained ongoing fidelity checks, it is
understood that the quality and content of the program was constant from year to year
and therefore the program year was not controlled for. Similarly, it was assumed that
there were no systematic differences between site locations and the quality and content of
the site locations were similar from year to year, therefore site location was not controlled
for. Psychotropic medications were not controlled for in this dissertation as well. The
focus of this dissertation was on the outcomes of children with ADHD enrolled in an
intensive behavioral program by age, gender, and comorbidity regardless of whether they
were prescribed psychotropic medication. While researchers may wish to further examine
the impact of medications, extant research has already demonstrated the efficacy of both
medication only (American Academy of Child and Adolescent Psychiatry, 2007) and
behavioral only treatment for ADHD.(Pelham & Fabiano, 2008) Combined treatment
(i.e., implementing medication and behavioral treatment concurrently; American
Academy of Pediatrics, 2001) continues to be the gold standard of care in the treatment of
ADHD, and whether or not combined treatment resulted in more improvement was not
one of the research questions of this study.
Another limitation involves the fact that this sample included data collected
during two STP years that involved research studies carried out within the context of the
program. In one study conducted by Fabiano et al. (2004), the time-out procedures
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utilized to manage more severe behaviors (e.g., repeated noncompliance, intentional
aggression, and intentional destruction of property) were varied in order to determine
their efficacy. In the other study conducted by Pelham et al. (2005), some children
participated in a multi-site, double-blind trial that involved various doses of a transdermal
methylphenidate patch and placebo. Data collected during such summers were not
excluded from this analysis. As part of the typical treatments available to all children in
the STP, parents were given the option to enroll their children in double-blind,
psychostimulant medication trials with or without placebo. Unlike the aforementioned
research trials, the medication trials were offered as a clinical service to parents of
children who were naïve to medication management. Parents and STP staff members
completed rating scales to determine a child’s response to and tolerability of varying
doses of medication and, when appropriate, compared to a placebo. In all three of these
instances, the archival database utilized for the present analyses did not include variables
that would identify children who may have participated. Therefore, it was neither
possible to exclude such participants, nor control for them in the models.
Demographically, the participants in this dissertation represent a more
homogeneous group lacking a robust ethnically and socio-economically diverse pool.
Likewise the archived data was from middle to higher socio-economic classes and from a
largely Caucasian racial background; therefore, inferences made or findings that are
applied to the general ADHD comorbidity population must be done with caution.
Another limitation lies within the comprehensive treatment program itself. It was not
possible to identify children in the program for whom ITPs were developed, and,
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therefore, future research may benefit from including this information so that a direct
analysis can be conducted.
Another possible limitation involves the screening process used for acceptance
into the STP, whereby children with more severe comorbidities may have been screened
out. This may have resulted in the lack of finding a significant difference between the
ADHD only and the ADHD Comorbidity groups (i.e., Type II error). Additionally, this
may have important clinical implications for future practice, as it would be beneficial to
better understand the impact that a child’s comorbidity severity may have on positive
outcomes. Additionally, quite similar to research question #1, and with the exception of
ODD, the absence of significant differences across other comorbidities in research
question #4 may have been impacted by the screening process, whereby children with
more severe expressions of mood, conduct, PDD, etc. were screened out of the STP. Had
these children been accepted into the STP and included in these analyses, differences may
have been uncovered, and researchers are encouraged to investigate this further.
Finally, a highly intensive intervention is quite structured and costly, and the program
is often difficult to replicate. Therefore, generalizing the positive results of the STP
treatment to the home and other school settings may be difficult. However, with the
current push for practitioners and teachers to utilize evidence-based treatments, more
studies ought to be conducted in naturalistic settings that incorporate certain elements of
the STP. This may allow for stronger claims of generalizability.
Conclusion
This dissertation has moved toward answering important questions regarding
treatment outcomes for children diagnosed with ADHD and comorbid diagnoses. Both
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children diagnosed with ADHD and those with ADHD plus a dual diagnosis showed
improvements over the course of the 7-week Summer Treatment Program, as children in
both groups earned more points from weeks two to six. By examining 14 years of
archival treatment data, this research provides additional support for treatment matching
of children with ADHD regardless of their gender, age, or presence of comorbidity. This
dissertation also provides evidence of the clinical utility of the STP for children
diagnosed with ADHD. Given that ADHD comorbidity is almost the rule rather than the
exception, this study provides additional support for the efficacy of the STP regardless of
the presence, type, or number of comorbidities.
In closing, one of the most common arguments against a manualized program like the
STP involves its lack of individualization. Those who argue against manualized
treatments suggest that such programs do not allow clinicians to adjust treatment in order
to meet the needs of their patients. However, the results of this dissertation suggest that
efficacious, manualized programs actually include individualized treatment as a core
component. Although highly regimented in its design and implementation, the STP
allows for the type of adjustment that is required based on each patient’s unique needs.
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STATISTICAL METHODOLOGY
Research Questions

Variables

Statistical Analysis

Do children diagnosed with ADHD

Dependent

Linear Mixed Effects

alone, who attend an intensive

STP point system

Methods

summer treatment program, differ in

Rate of change

treatment outcomes from those

Independent

children diagnosed with ADHD

ADHDType

comorbidity?

Comorbidity type

Do males diagnosed with ADHD

Dependent

Linear Mixed Effects

comorbidity who attend an intensive

STP point system

Methods

summer treatment program, differ in

Rate of change

treatment outcomes from females

Independent

with ADHD comorbidity?

Gender

Are there age group differences in

Dependent

Linear Mixed Effects

treatment outcomes with children

STP point system

Methods

diagnosed with ADHD comorbidity,

Rate of change

who attend an intensive summer

Independent

treatment program?

Comorbidity Types
Age group

Do children with different comorbid

Dependent

Linear Mixed Effects

diagnoses and ADHD, who attend an

STP point system

Methods

intensive summer treatment program,

Rate of change

differ in treatment outcomes?

Independent
ADHDType

131

APPENDIX D
TABLES OF MODEL SUMMARY FOR TOTAL WEEKLY POINTS

132

APPENDIX D
TABLES OF MODEL SUMMARY FOR TOTAL WEEKLY POINTS
Model Summary for Total Weekly Points (Anxiety Comorbidity).
Factor

Level

(Intercept)
Anxiety D/O, OCD,
Yes vs. No
PTSD
Week/time
3 vs. 2
4 vs. 2
5 vs. 2
6 vs. 2
Age
Race
Other vs. Caucasian
Gender

Male vs. Female

Beta

95% Confidence
Interval

-677.0

(-5139.07, 3784.96)

-734.3

(-2613.69, 1145.16)

443.9
1325.8
1250.2
1856.7
2505.1
492.2
1389.5

(-294.25, 1182.16)
(595.32, 2056.18)
(515.8, 1984.63)
(1117.25, 2596.07)
(1096.87, 3913.27)
(-1142.59, 2127)
(-3143.41, 364.44)

T
0.30
0.77
1.18
3.56
3.34
4.93
3.49
0.59
1.55

Model Summary for Total Weekly Points (Mood Comorbidity).
Factor
Level
(Intercept)
Mood
Yes vs. No
Week/time 3 vs. 2
4 vs. 2
5 vs. 2
6 vs. 2
Age
Race
Other vs. Caucasian
Gender
Male vs. Female

Beta 95% Confidence Interval
-1000.8
(-5340.23, 3338.58)
-394.4
(-2366.29, 1577.4)
641.8
(-126.29, 1409.86)
1583.8
(825.33, 2342.2)
1576.9
(817.24, 2336.56)
2103.6
(1335.49, 2871.75)
832.2
(380.1, 1284.38)
319.9
(-1323.97, 1963.83)
-1126.4
(-2917.8, 665.06)
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T P-value (T)
-0.45
0.65
-0.39
0.69
1.64
0.10
4.10
< 0.001
4.07
< 0.001
5.37
< 0.001
3.61
< 0.001
0.38
0.70
-1.23
0.22

P-value
(T)
0.77
0.44
0.24
< 0.001
< 0.001
< 0.001
< 0.001
0.55
0.12

Model Summary for Total Weekly Points (Oppositional Defiance Disorder).
Factor
Level
(Intercept)
ODD
Yes vs. No
Week/time 3 vs. 2
4 vs. 2
5 vs. 2
6 vs. 2
Age
Race
Other vs. Caucasian
Gender
Male vs. Female

Beta
95% Confidence Interval
-3031.82
(-7698.38, 1634.74)
-2048.70
(-4015.76, -81.64)
394.02
(-432.61, 1220.65)
1065.70
(246.5, 1884.89)
1142.91
(322.44, 1963.39)
1574.41
(745.16, 2403.66)
1085.31
(597.6, 1573.01)
34.92
(-1705.14, 1774.97)
-655.06
(-2569.95, 1259.82)

T P-value (T)
-1.27
0.20
-2.04
0.041
0.94
0.35
2.55
0.011
2.73
0.006
3.73
< 0.001
4.37
< 0.001
0.04
0.97
-0.67
0.50

Model Summary for Total Weekly Points (PDD, aspergers, autism spectrum).

Factor

Level

(Intercept)

Beta
-1339.2

PDD, aspergers,
autism spectrum

Yes vs. No

Week/time

3 vs. 2

653.1

4 vs. 2

1468.6

5 vs. 2

1497.8

6 vs. 2

1959.4

-1145.0

Age

885.9

Race

Other vs. Caucasian

Gender

Male vs. Female

542.3
-1278.7
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95%
Confidence
Interval
(-5831.16,
3152.66)
(-3524.84,
1234.86)
(-142.4,
1448.55)
(681.03,
2256.2)
(707.6,
2288.05)
(1159.77,
2759.07)
(421.5,
1350.34)
(-1268.56,
2353.11)
(-3223.95,
666.52)

T

P-value
(T)

-0.59

0.56

-0.94

0.35

1.61

0.11

3.66

< 0.001

3.72

< 0.001

4.81

< 0.001

3.74

< 0.001

0.59

0.56

-1.29

0.20

Model Summary for Total Weekly Points (Tic-Tourettes Comorbidity).
Factor
Level
(Intercept)
Tic-Tourettes Yes vs. No
Week/time
3 vs. 2
4 vs. 2
5 vs. 2
6 vs. 2
Age
Race
Other vs. Caucasian
Gender
Male vs. Female

Beta 95% Confidence Interval
-574.8
(-5166.07, 4016.42)
532.2
(-1969.45, 3033.85)
507.1
(-312.37, 1326.63)
1428.2
(618.38, 2237.94)
1543.2
(732.06, 2354.45)
1982.2
(1161.25, 2803.26)
783.8
(306.48, 1261.08)
550.0
(-1221.66, 2321.62)
-1134.2
(-3062.67, 794.25)

T P-value (T)
-0.25
0.81
0.42
0.68
1.21
0.22
3.46
< 0.001
3.73
< 0.001
4.74
< 0.001
3.22
0.001
0.61
0.54
-1.15
0.25

Model Summary for Total Weekly Points (Learning Disorder Comorbidity).
Factor
Level
(Intercept)
Learning disorder Yes vs. No
Week/time
3 vs. 2
4 vs. 2
5 vs. 2
6 vs. 2
Age
Race
Other vs. Caucasian
Gender
Male vs. Female

Beta 95% Confidence Interval
-1125.6
(-5347.38, 3096.27)
884.0
(-924.06, 2692.02)
508.3
(-236.82, 1253.35)
1294.0
(559.18, 2028.9)
1554.4
(818.39, 2290.41)
2054.4
(1310.46, 2798.38)
860.2
(424.04, 1296.47)
546.8
(-1004.09, 2097.76)
-1234.0
(-2931.34, 463.35)
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T
P-value (T)
-0.52
0.60
0.96
0.34
1.34
0.18
3.46
< 0.001
4.14
< 0.001
5.42
< 0.001
3.87
< 0.001
0.69
0.49
-1.43
0.15

Model Summary for Total Weekly Points (Number of comorbidities).

Factor

Level

Beta

SE

-0.07

1808.9

1 vs. 0

-358.02

669.7

2 vs. 0

-189.46

1098.0

3 vs. 0

-843.59

1544.8

3 vs. 2

793.00

296.7

4 vs. 2

1419.20

293.2

5 vs. 2

1735.13

294.1

6 vs. 2

2177.07

295.3

755.80

183.6

(Intercept)
Number of
Comorbidities

Week/time

Age
Race

Other vs. Caucasian

-126.02

682.8

Gender

Male vs. Female

-1482.08

749.0
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95%
Confidence
Interval
(-3547.96,
3547.81)
(-1671.58,
955.53)
(-2342.99,
1964.08)
(-3873.62,
2186.44)
(211.11,
1374.89)
(844.2,
1994.19)
(1158.26,
2312.01)
(1597.86,
2756.28)
(395.65,
1115.95)
(-1465.21,
1213.16)
(-2951.06, 13.09)

T

P-value
(T)

0.00

> 0.99

-0.53

0.59

-0.17

0.86

-0.55

0.59

2.67

0.008

4.84

< 0.001

5.90

< 0.001

7.37

< 0.001

4.12

< 0.001

-0.18

0.85

-1.98

0.048

